Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
43055225	li-fostau	ng/l (ng/l)	1604	1636	0.43%
43055225	li-fostau	— (—)	704	720	100.00%	Distribution not available
43055225	li-fosftau	ng/l (ng/l)	13	13	0.00%
43055225	li-fosfo-tauproteiini,likvor	ng/l (ng/l)	5	5	0.00%	Distribution not available	Distribution not available
43055225	li-fos-tau	— (—)	5	6	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Implicit Sepsis

1173

1004

8.72

307.65

1.0

38.83

45.79

ng/l

2.48

940

604

N06DA Anticholinesterases

888

455

16.21

307.65

1.0

53.26

36.82

ng/l

13.18

654

268

Psychiatric diseases

837

448

9.46

307.65

1.0

43.71

29.64

ng/l

13.83

592

295

Condition for Implicit Sepsis (Organ dysfunction codes)

1392

684

14.36

307.65

1.0

40.73

44.00

ng/l

0.76

1107

361

Condition for Implicit Sepsis (Organ dysfunction codes)

1347

801

12.16

307.65

1.0

39.91

45.34

ng/l

1.56

1080

439

Other degenerative diseases of the nervous system

952

145

52.19

307.65

1.0

50.44

39.03

ng/l

3.44

722

109

Alzheimer disease

793

391

15.58

307.65

1.0

55.74

36.14

ng/l

16.20

581

224

Normal-pressure hydrocephalus

342

47.03

307.65

1.1

1.0

30.09

49.00

ng/l

2.78

Other mental disorders due to brain damage and dysfunction and to physical disease

402

125

34.94

307.65

1.0

42.94

29.80

ng/l

5.37

276

Alzheimer’s disease, strict definition

696

313

19.36

307.65

1.0

57.01

36.23

ng/l

15.01

521

175

Any dementia, excluding more controls

981

325

21.94

307.65

1.0

1.1

51.26

36.06

ng/l

9.18

731

186

Unspecific neurodegenerative disorder

1067

418

18.34

307.65

1.0

51.75

34.08

ng/l

18.52

773

246

Symptoms and signs involving cognition, perception, emotional state and behaviour

1465

709

14.41

307.65

1.0

41.58

41.52

ng/l

0.01

1158

370

Alzheimer’s disease (Late onset)

480

287

14.66

307.65

1.0

57.30

36.40

ng/l

11.95

348

161

Alzheimer disease, excluding more controls

758

201.81

307.65

1.0

1.1

55.26

34.89

ng/l

5.57

562

Use of donepezil

520

353

14.89

307.65

1.0

57.73

40.21

ng/l

8.94

393

203

Use of memantine

513

394

11.20

307.65

1.0

56.58

42.74

ng/l

5.39

366

226

Use of anticholinesterases

888

455

16.21

307.65

1.0

53.26

36.82

ng/l

13.18

654

268

Dementia

1137

350

23.56

307.65

1.0

49.79

32.89

ng/l

17.35

832

203

Alzheimer’s disease (Late onset), excluding more controls

465

154.58

307.65

1.0

1.1

56.89

35.41

ng/l

5.66

340

Alzheimer’s disease (Early onset)

243

70.62

307.65

1.0

58.17

32.34

ng/l

5.91

189

Any mental disorder

968

722

6.79

307.65

1.0

44.12

32.09

ng/l

11.22

692

468

Any dementia

993

429

16.91

307.65

1.0

51.50

35.52

ng/l

13.23

738

244

Other symptoms and signs involving cognitive functions and awareness

1397

485

27.76

307.65

1.0

41.34

45.69

ng/l

0.98

1145

249

Implicit Sepsis

949

1181

6.17

307.65

1.0

38.91

44.48

ng/l

1.58

751

757

Hydrocephalus

367

136

30.43

307.65

1.1

1.0

30.01

47.83

ng/l

3.82

109

Dementia in Alzheimer disease

322

122

23.11

307.65

1.0

57.43

32.43

ng/l

9.07

201

Use of other anti-dementia drugs

513

394

11.20

307.65

1.0

56.58

42.74

ng/l

5.39

366

226

Alzheimer disease, including avohilmo

903

420

15.89

307.65

1.0

54.71

35.69

ng/l

17.24

656

243

Degenerative diseases of the nervous system

975

429

17.63

307.65

1.0

51.19

37.24

ng/l

9.65

733

253

Organic, including symptomatic, mental disorders

1339

444

22.59

307.65

1.0

47.66

31.53

ng/l

20.69

963

269

Dementia, including avohilmo

1191

425

20.29

307.65

1.0

48.75

32.99

ng/l

17.04

872

246

Use of rivastigmine

321

287

11.68

307.21

1.0

49.48

45.06

ng/l

0.71

236

165

Depression or dysthymia

424

253

9.33

254.54

1.0

37.02

29.06

ng/l

3.28

290

163

Intracranial trauma

346

265

9.25

238.65

1.0

39.58

35.09

ng/l

0.77

226

202

Mood disorders, excluding more controls

593

704

5.07

227.20

1.0

35.20

31.65

ng/l

1.22

412

462

Memory loss

177

19.74

226.73

1.0

41.10

30.79

ng/l

2.33

135

Other neurological diseases

677

1363

3.95

214.33

1.0

37.32

44.25

ng/l

2.54

357

1043

Unspecified dementia

168

21.59

209.26

1.0

45.32

34.48

ng/l

1.85

133

Circumscribed brain atrophy

123

48.41

207.74

1.0

34.81

27.92

ng/l

0.79

Neurological diseases

441

327

6.82

202.06

1.0

44.32

33.67

ng/l

3.99

304

248

Concussion

270

265

8.37

187.84

1.0

41.01

35.09

ng/l

0.98

181

202

Implicit viral Sepsis

299

477

6.38

178.26

1.1

1.0

35.61

46.11

ng/l

3.94

226

289

Symptoms and signs involving the nervous and musculoskeletal systems

520

1348

3.90

174.31

1.0

39.15

43.16

ng/l

0.42

331

950

Parkinson's disease, excluding more controls

113

37.34

174.20

1.0

1.1

33.72

34.55

ng/l

0.08

Dizziness and giddiness

412

666

4.94

173.09

1.0

40.93

42.77

ng/l

0.26

267

344

Parkinson's disease, strict definition, excluding more controls

101

34.92

154.20

1.0

1.1

32.83

35.30

ng/l

0.27

Implicit bacterial Sepsis

391

798

4.28

142.26

1.0

36.01

45.84

ng/l

5.15

303

488

Recurrent or chronic depression

202

153

9.35

140.56

1.0

33.57

29.76

ng/l

0.64

132

102

Other and unspecified degenerative diseases of nervous system

27.28

135.36

1.1

1.0

38.28

35.99

ng/l

0.13

Other antidepressants

655

1057

3.19

132.42

1.0

39.32

42.25

ng/l

0.87

433

763

Undefined dementia

168

182

8.73

126.93

1.0

45.32

44.95

ng/l

0.03

133

Delirium, not induced by alcohol and other psychoactive substances

127

108

12.00

125.26

1.0

39.21

30.44

ng/l

1.56

Alzheimer’s disease (Atypical or mixed)

126

105

12.23

125.14

1.0

1.1

47.07

35.11

ng/l

1.29

Implicit bacterial Sepsis

333

747

4.00

111.71

1.0

37.62

45.67

ng/l

3.24

255

461

Anxiety disorders, excluding more controls

376

643

3.82

107.72

1.0

34.65

31.50

ng/l

0.91

286

427

Other symptoms and signs involving the nervous and musculoskeletal systems

332

908

3.70

103.33

1.0

37.37

43.37

ng/l

1.69

217

639

Use of galantamine

130

158

8.53

99.61

1.1

1.0

54.31

46.32

ng/l

0.74

Abnormalities of gait and mobility

165

263

6.45

99.01

1.0

42.29

48.86

ng/l

0.17

169

Vascular dementia

12.90

98.27

1.0

43.10

33.32

ng/l

1.26

Viral Sepsis

187

354

5.37

93.46

1.1

1.0

35.00

48.05

ng/l

3.81

132

211

Bacterial Sepsis

336

825

3.51

93.03

1.0

37.74

45.18

ng/l

2.96

257

507

Implicit viral Sepsis

186

354

5.34

92.41

1.1

1.0

35.00

48.05

ng/l

3.81

132

211

Selective serotonin reuptake inhibitors

563

1057

2.79

92.38

1.0

41.69

42.25

ng/l

0.09

372

763

Schizophrenia or delusion, excluding more controls

160

266

6.00

90.30

1.0

49.99

31.97

ng/l

0.88

123

169

Dementia in other diseases classified elsewhere

16.60

88.53

1.0

36.68

31.01

ng/l

0.54

Medical observation and evaluation for suspected diseases and conditions

386

610

3.25

80.60

1.0

41.38

41.83

ng/l

0.06

230

470

Traumatic subdural haemorrhage

10.29

78.89

1.0

40.24

43.09

ng/l

0.19

Mood [affective] disorders

598

1614

2.41

78.87

1.0

35.19

43.54

ng/l

3.76

417

1146

Mood disorders

598

1618

2.40

78.15

1.0

35.05

43.68

ng/l

3.99

416

1151

Depression

545

1551

2.39

71.51

1.0

34.71

43.66

ng/l

4.64

375

1108

Substance abuse, excluding more controls

238

567

3.60

68.67

1.0

40.46

31.78

ng/l

3.01

173

377

Malaise and fatigue

340

969

2.84

65.67

1.0

39.58

45.23

ng/l

1.07

234

672

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

136

7.13

64.87

1.0

40.15

42.55

ng/l

0.17

Vascular dementia (subcortical)

18.02

63.85

1.1

1.0

49.48

31.02

ng/l

1.41

Extrapyramidal and movement disorders

287

974

2.98

63.25

1.0

35.30

44.21

ng/l

2.63

188

662

Nonorganic sleeping disorders, excluding more controls

132

7.10

62.06

1.0

31.42

32.69

ng/l

0.12

Other and unspecified hydrocephalus

16.95

61.21

1.1

1.0

27.11

38.68

ng/l

0.83

Neurological diseases, wide definition

104

9.53

59.98

1.0

41.21

28.03

ng/l

1.64

Injuries to the head

584

1708

2.11

55.87

1.0

39.39

42.47

ng/l

0.74

401

1206

Epilepsy

203

614

3.32

54.09

1.0

36.68

42.50

ng/l

1.52

148

425

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

102

183

5.58

53.74

1.0

37.81

33.12

ng/l

0.33

122

Postprocedural disorders of nervous system

8.75

53.02

1.0

52.48

39.88

ng/l

0.78

Psychotic depression

21.95

52.55

1.0

1.1

27.71

35.32

ng/l

0.42

Benzodiazepine use

538

1770

2.10

52.36

1.0

40.60

41.94

ng/l

0.26

380

1233

General examination and investigation of persons without complaint and reported diagnosis

320

610

2.75

51.41

1.0

36.68

41.83

ng/l

1.43

212

470

Depression medications

127

132

4.86

43.60

1.0

39.76

46.73

ng/l

0.66

102

Intracranial injury

317

1283

2.35

43.36

1.0

40.11

42.16

ng/l

0.30

203

875

Personality disorders, excluding more controls

180

5.08

43.36

1.0

31.83

32.26

ng/l

0.05

119

Convulsions, not elsewhere classified

145

418

3.45

41.09

1.0

36.70

43.62

ng/l

1.30

103

297

Use of levodopa decarboxylase inhibitor

128

355

3.66

39.53

1.0

30.94

45.51

ng/l

5.23

227

Bipolar affective disorders

109

270

4.07

39.37

1.0

34.49

45.96

ng/l

1.26

203

General symptoms and signs

503

1278

1.98

38.71

1.0

38.55

43.00

ng/l

1.12

341

917

Syncope and collapse

260

915

2.45

38.20

1.0

37.31

43.21

ng/l

1.69

170

634

Kela-code for severe mental illness

204

760

2.70

37.97

1.0

44.80

41.07

ng/l

0.15

147

536

Unspecified mental disorder

218

847

2.59

37.28

1.0

44.20

41.49

ng/l

0.11

159

592

Persons encountering health services for examination and investigation

292

610

2.41

36.09

1.0

42.52

41.83

ng/l

0.08

191

470

Other special examinations and investigations of persons without complaint or reported diagnosis

289

610

2.41

35.78

1.0

42.38

41.83

ng/l

0.06

193

470

Fall on same level

533

1562

1.87

35.65

1.0

45.13

40.09

ng/l

0.66

376

1114

Other extrapyramidal and movement disorders in other diseases

165

584

2.85

34.00

1.0

39.38

44.57

ng/l

0.61

111

402

Focal epilepsy

142

471

3.04

32.86

1.0

37.17

43.26

ng/l

1.17

319

Other symptoms and signs involving general sensations and perceptions

11.18

32.06

1.0

38.48

33.00

ng/l

0.39

Examination and observation for other reasons

249

610

2.37

31.15

1.0

38.39

41.83

ng/l

0.71

161

470

Other degenerative diseases of the basal ganglia

9.00

30.82

1.1

1.0

31.73

44.63

ng/l

1.20

Focal epilepsy, mode (most common among epilepsy diagnosis)

128

416

3.11

30.73

1.0

37.18

43.51

ng/l

1.17

280

Focal epilepsy, strict definition

131

446

2.96

29.03

1.0

37.59

42.94

ng/l

0.92

302

Communicating hydrocephalus

9.82

29.02

1.2

1.0

33.65

37.75

ng/l

0.14

Anxiety (asthma-related co-morbidities)

246

857

2.23

28.84

1.0

35.18

41.76

ng/l

1.80

184

622

Parkinson's disease, including avohilmo

126

428

2.98

28.12

1.0

33.37

44.31

ng/l

3.25

279

Non-selective monoamine reuptake inhibitors

186

739

2.44

28.02

1.0

35.62

44.18

ng/l

2.48

124

538

Implicit fungal Sepsis

110

5.18

27.13

1.0

32.92

51.98

ng/l

2.98

Other anxiety disorders

188

690

2.37

26.12

1.0

36.34

41.53

ng/l

1.02

137

487

Schizophrenia, schizotypal and delusional disorders

162

656

2.48

25.63

1.0

49.87

40.12

ng/l

0.39

124

461

Headache

283

1131

2.00

25.52

1.0

37.16

43.74

ng/l

1.61

190

812

Infections, IBD-co-morbidities

6.48

25.16

1.0

37.41

28.32

ng/l

1.02

Schizophrenia or delusion

160

651

2.47

25.06

1.0

49.99

40.09

ng/l

0.39

123

460

Cerebrovascular diseases

404

1596

1.79

24.95

1.0

37.64

43.69

ng/l

1.92

268

1121

Hypothyroidism (congenital or acquired)

131

3.85

24.87

1.0

44.51

47.06

ng/l

0.13

101

Other disorders of urethra and urinary system

335

1292

1.88

24.48

1.0

37.56

43.27

ng/l

2.03

229

886

Episodal and paroxysmal disorders

453

1320

1.75

24.41

1.0

40.07

44.17

ng/l

0.92

304

927

Other and unspecified nonorganic psychotic disorders

313

3.15

24.33

1.0

58.64

42.56

ng/l

0.40

215

Hypothyroidism, levothyroxine purchases

130

3.80

23.90

1.0

45.11

47.06

ng/l

0.10

101

Hypothyroidism and >3 levothyroxin purchases

130

3.80

23.90

1.0

45.11

47.06

ng/l

0.10

101

Progressive vascular leukoencephalopathy

6.37

22.80

1.1

1.0

31.92

38.91

ng/l

0.68

Parkinson's disease

113

407

2.81

22.76

1.0

33.72

44.58

ng/l

2.91

263

Constipation

429

1760

1.69

21.99

1.0

44.14

41.92

ng/l

0.18

303

1223

STROKE

317

1171

1.85

21.82

1.0

36.88

44.17

ng/l

2.05

226

841

Focal brain injury

7.56

21.21

1.0

25.52

36.66

ng/l

1.13

Disorders of thyroid, IBD co-morbidities

5.64

20.63

1.0

38.75

28.03

ng/l

1.11

All anxiety disorders

246

1005

1.94

20.31

1.0

35.18

42.93

ng/l

1.75

184

712

Manic episode

8.09

20.07

1.0

48.65

54.81

ng/l

0.10

Covid-19 confirmed case

181

862

2.11

19.65

1.1

1.0

40.60

43.59

ng/l

0.47

127

572

Parkinson's disease, strict definition

101

374

2.73

19.37

1.0

32.83

45.99

ng/l

3.54

239

severe traumatic brain injury, does not include concussion

132

557

2.39

19.25

1.0

36.31

43.71

ng/l

1.23

366

Open wound of head

246

1274

1.87

18.79

1.0

40.37

41.77

ng/l

0.21

172

882

Abnormal involuntary movements

275

2.97

18.25

1.0

32.95

45.80

ng/l

2.23

186

Anxiety disorders

379

1596

1.66

18.20

1.0

34.51

42.69

ng/l

3.30

288

1114

Alcohol abuse, main dg, excluding more controls

138

3.86

18.07

1.0

1.1

37.32

31.07

ng/l

0.64

Neurotic, stress-related and somatoform disorders

373

1577

1.66

17.94

1.0

34.40

42.47

ng/l

3.19

282

1104

Metabolic disorders

424

1607

1.61

17.81

1.0

36.17

43.90

ng/l

2.82

302

1111

Provisional assignment of new diseases of uncertain etiology

227

1220

1.86

17.39

1.1

1.0

38.04

41.95

ng/l

0.87

164

818

Codes for special purposes

227

1222

1.86

17.30

1.1

1.0

38.04

42.12

ng/l

0.93

164

819

Sequelae of injuries of head

105

4.26

16.96

1.0

35.25

39.11

ng/l

0.23

Nonorganic sleeping disorders

356

2.63

16.73

1.0

31.42

42.49

ng/l

2.44

248

Care involving use of rehabilitation procedures

306

1668

1.69

16.67

1.0

34.28

42.84

ng/l

3.53

246

1149

Dorsalgia

392

1295

1.62

16.51

1.0

38.19

43.19

ng/l

1.50

247

945

Other dorsopathies, not elsewhere classified

398

1295

1.61

16.16

1.0

39.69

43.19

ng/l

0.79

252

945

Other intervertebral disc disorders

352

1293

1.64

15.91

1.0

42.91

43.22

ng/l

0.02

235

944

Superficial injury of head

111

473

2.36

15.90

1.0

37.44

45.50

ng/l

1.32

323

Lower back pain or/and sciatica

442

1872

1.55

15.74

1.0

41.84

41.64

ng/l

0.01

274

1345

Disorders of lipoprotein metabolism and other lipidaemias

400

1569

1.58

15.65

1.0

36.50

44.20

ng/l

2.72

296

1085

Falls/tendency to fall

419

1331

1.58

15.53

1.0

40.01

40.12

ng/l

0.02

291

946

Spondylopathies

351

1287

1.63

15.50

1.0

35.11

43.29

ng/l

4.33

221

941

Speech disturbances, not elsewhere classified

204

3.12

15.49

1.1

1.0

30.23

43.57

ng/l

2.59

124

Anaemias

130

3.27

15.44

1.0

41.61

47.06

ng/l

0.43

101

Cerebrovascular diseases (FINNGEN)

177

633

1.99

15.43

1.0

34.61

44.88

ng/l

3.29

130

473

Schizoaffective disorder

133

3.65

15.07

1.0

37.63

45.30

ng/l

0.29

Monoamine oxidase A inhibitors

188

3.16

14.89

1.1

1.0

38.97

46.36

ng/l

0.57

139

Follow-up examination after treatment for conditions other than malignant neoplasms

156

504

2.05

14.72

1.0

34.91

42.80

ng/l

2.17

115

393

Poisoning by medicine

371

2.47

14.43

1.0

32.08

44.38

ng/l

3.12

264

Persons encountering health services for specific procedures and health care

436

1728

1.52

14.07

1.0

36.35

42.90

ng/l

2.61

328

1190

Parasetamol

276

820

1.71

13.98

1.0

38.30

40.90

ng/l

0.52

184

630

Poisoning by drugs, medicaments and biological substances

420

2.34

13.93

1.0

32.57

43.93

ng/l

2.96

297

Pure hypercholesterolaemia

366

1529

1.57

13.92

1.0

35.27

44.36

ng/l

3.82

268

1057

Low back pain

295

1294

1.64

13.82

1.0

36.45

43.19

ng/l

2.24

190

945

Generalized anxiety disorder

171

3.17

13.77

1.0

39.64

44.90

ng/l

0.38

114

Other disorders of ear

412

1781

1.52

13.63

1.0

45.21

40.92

ng/l

0.38

281

1264

Sleep disorders (combined)

449

1570

1.50

13.60

1.0

37.34

44.31

ng/l

2.62

317

1085

Shoulder lesions

349

1357

1.56

12.96

1.0

37.19

43.06

ng/l

1.72

242

949

Sequelae of cerebrovascular disease

175

820

1.85

12.89

1.0

37.65

44.50

ng/l

1.51

124

544

Viral infections of the central nervous system

120

3.53

12.65

1.0

40.06

42.62

ng/l

0.12

Malignant neoplasm of digestive organs

1090

0.36

12.57

1.0

34.28

43.45

ng/l

1.44

731

Factors influencing health status and contact with health services

123

286

2.16

12.40

1.0

42.66

45.67

ng/l

0.22

223

Abnormal findings on diagnostic imaging of central nervous system

3.88

12.37

1.1

1.0

27.74

44.76

ng/l

1.89

Sciatica+with lumbago

221

1205

1.69

12.22

1.0

45.51

42.83

ng/l

0.10

132

887

Other sleep disorders

228

2.74

12.21

1.0

38.81

45.81

ng/l

0.80

159

Secondary parkinsonism+Parkinsonism in other disease

4.83

12.17

1.0

27.83

46.48

ng/l

1.03

Other encephalitis

5.57

12.15

1.0

41.71

34.33

ng/l

0.41

Symptoms and signs involving speech and voice

156

843

1.86

12.03

1.0

48.36

42.90

ng/l

0.20

126

562

Other diseases of urinary system

405

1532

1.49

11.94

1.0

39.36

42.05

ng/l

0.65

283

1065

259

1416

1.61

11.88

1.0

40.58

40.63

ng/l

0.01

184

988

Viral encephalitis, not elsewhere classified/unspecified

5.97

11.85

1.0

45.04

37.01

ng/l

0.26

Statin medication

231

767

1.70

11.79

1.0

37.77

44.44

ng/l

1.14

153

559

Viral infections of the central nervous system

131

3.31

11.76

1.0

41.34

42.41

ng/l

0.05

Other reaction to severe stress, and adjustment disorders

128

653

1.97

11.73

1.0

30.77

41.74

ng/l

3.51

468

Lumbar disc prolapse

267

1278

1.61

11.73

1.0

44.92

43.13

ng/l

0.08

175

938

Cerebral cysts

4.12

11.59

1.0

33.35

45.24

ng/l

0.78

Dysphagia

128

658

1.96

11.51

1.0

37.76

42.72

ng/l

0.90

432

Other headache syndromes

160

883

1.82

11.49

1.0

36.25

44.48

ng/l

1.58

103

622

Dorsopathies

382

1296

1.50

11.49

1.0

39.64

43.16

ng/l

0.77

244

946

Behavioural syndromes associated with physiological disturbances and physical factors

356

1686

1.50

11.41

1.0

33.19

43.15

ng/l

4.96

255

1182

Other functional intestinal disorders

203

1114

1.70

11.37

1.0

39.66

43.25

ng/l

0.44

145

760

Mental and behavioural disorders due to psychoactive substance use

247

1426

1.61

11.28

1.0

40.19

40.23

ng/l

0.01

181

1001

Secondary parkinsonism

4.65

11.22

1.0

28.82

42.66

ng/l

0.64

Degeneration of the brain due to alcohol

5.65

11.22

1.0

1.1

48.19

34.79

ng/l

0.76

Somnolence, stupor and coma

5.58

11.18

1.0

1.1

27.35

32.23

ng/l

0.33

Conductive and sensorineural hearing loss

367

1673

1.48

11.06

1.0

46.96

41.64

ng/l

0.43

249

1176

246

1390

1.60

11.05

1.0

40.81

40.31

ng/l

0.07

177

968

Fever of other and unknown origin

208

1109

1.67

11.04

1.0

37.52

43.84

ng/l

1.37

133

781

Unspecified fall

210

1249

1.66

11.01

1.0

46.17

42.45

ng/l

0.16

152

844

Non-invasive ventilation

103

443

2.08

10.88

1.1

1.0

31.68

44.09

ng/l

3.81

321

Pain in throat and chest

332

1319

1.51

10.83

1.0

35.02

43.98

ng/l

3.41

241

913

Mental and behavioural disorders due to alcohol

218

1283

1.64

10.78

1.0

40.80

40.14

ng/l

0.09

157

900

Encephalitis

4.97

10.76

1.0

41.71

31.77

ng/l

0.62

Other diseases of intestines

398

1553

1.46

10.75

1.0

37.85

41.13

ng/l

0.87

277

1089

Persistent mood disorders

360

2.26

10.70

1.0

38.46

46.08

ng/l

1.08

259

Symptoms and signs involving the urinary system

333

1713

1.48

10.32

1.0

42.84

42.17

ng/l

0.09

238

1176

Substance abuse

238

1414

1.59

10.30

1.0

40.46

40.34

ng/l

0.02

173

994

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

102

505

2.03

10.24

1.0

37.81

42.09

ng/l

0.30

362

Alcohol use disorder, Swedish definition

233

1345

1.59

10.23

1.0

40.91

40.02

ng/l

0.14

165

943

Persistent delusional disorders

165

2.88

10.16

1.0

41.78

45.60

ng/l

0.26

102

Disorders of adult personality and behaviour

473

2.06

10.16

1.0

37.69

42.37

ng/l

0.31

343

Cervicalgia

454

2.08

10.11

1.0

37.30

44.33

ng/l

0.98

331

Spinal stenosis

240

1151

1.59

10.11

1.0

34.75

44.61

ng/l

4.43

144

835

Other external causes of accidental injury

304

997

1.53

10.05

1.0

40.76

41.21

ng/l

0.07

217

682

Transient ischemic attack

246

1273

1.57

9.95

1.0

37.53

43.44

ng/l

1.84

169

848

Use of hypnotics and sedatives

429

1746

1.41

9.79

1.0

43.11

41.48

ng/l

0.13

313

1209

Hypotension

414

2.11

9.76

1.0

38.63

43.90

ng/l

0.60

263

Sleep disorders

333

1647

1.46

9.58

1.0

33.36

42.77

ng/l

4.27

241

1153

Bleeding

359

1780

1.44

9.38

1.0

39.90

42.65

ng/l

0.42

234

1258

Sensorineural hearing loss

348

1637

1.45

9.33

1.0

47.63

41.93

ng/l

0.44

235

1144

Vascular dementia (mixed)

10.21

9.06

1.0

1.1

45.00

34.03

ng/l

—

Accidents

298

997

1.50

9.05

1.0

41.13

41.21

ng/l

0.01

214

682

Other soft tissue disorders, not elsewhere classified

337

1364

1.45

8.96

1.0

37.37

43.01

ng/l

1.37

231

952

Suicide or other Intentional self-harm

490

1.97

8.92

1.0

38.48

42.33

ng/l

0.25

350

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

823

0.32

8.80

1.0

33.36

44.34

ng/l

0.71

546

Pain in limb

299

1363

1.47

8.74

1.0

35.07

43.01

ng/l

2.54

205

952

Other CVD (FINNGEN)

271

2.16

8.51

1.1

1.0

39.33

48.12

ng/l

1.04

188

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

131

2.92

8.51

1.1

1.0

36.64

42.30

ng/l

0.47

Diseases of oesophagus, stomach and duodenum

412

1787

1.38

8.38

1.0

45.19

41.04

ng/l

0.39

302

1241

Nerve, nerve root and plexus disorders

417

1863

1.37

8.24

1.0

40.59

41.98

ng/l

0.25

302

1290

Transient global amnesia

123

2.95

8.22

1.0

50.96

32.05

ng/l

1.12

Personality disorders

470

1.94

8.21

1.0

31.83

42.39

ng/l

2.94

337

Persons encountering health services in other circumstances, wide

454

1722

1.36

8.16

1.0

39.09

43.17

ng/l

0.47

350

1162

Mental and behavioural disorders due to alcohol, excluding acute intoxication

188

1190

1.58

8.13

1.0

41.63

39.80

ng/l

0.28

136

844

External causes of morbidity and mortality

241

792

1.53

8.03

1.0

42.04

41.96

ng/l

0.01

167

543

Stroke, including SAH

280

1403

1.45

7.82

1.0

37.29

42.49

ng/l

1.37

180

963

Traumatic subarachnoid haemorrhage

7.46

7.68

1.1

1.0

25.75

33.91

ng/l

0.70

Sleep apnoea

376

1771

1.38

7.67

1.0

38.08

42.65

ng/l

1.33

259

1243

Heart failure and coronary heart disease

1018

0.51

7.64

1.0

36.48

44.02

ng/l

1.66

689

Diseases of oral cavity, salivary glands and jaws

249

857

1.50

7.64

1.0

46.22

41.37

ng/l

0.84

157

588

Rotator cuff syndrome

272

1348

1.45

7.60

1.0

37.10

43.14

ng/l

1.52

192

943

Dental operations

261

908

1.48

7.56

1.0

46.30

39.94

ng/l

1.17

166

622

Hypertension, essential

308

1225

1.43

7.52

1.0

35.71

42.80

ng/l

2.41

226

866

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.98

7.51

1.0

30.86

32.00

ng/l

0.04

Hyperplasia of prostate

175

620

1.61

7.48

1.0

39.14

40.63

ng/l

0.20

125

416

Migraine without aura

233

2.28

7.32

1.0

33.89

42.41

ng/l

0.83

168

Alcohol use disorder, ICD-based

171

1100

1.56

7.12

1.0

41.47

39.81

ng/l

0.24

123

778

Sleep apnoea, including avohilmo

389

1784

1.35

7.09

1.0

38.01

42.54

ng/l

1.33

267

1254

Any gastric operation

272

943

1.45

7.09

1.0

42.22

41.41

ng/l

0.11

174

741

GASTRO-related operations

272

943

1.45

7.09

1.0

42.22

41.41

ng/l

0.11

174

741

Other CVD

491

1.84

6.95

1.0

38.23

44.26

ng/l

0.77

311

Degeneration of nervous system due to alcohol

3.76

6.95

1.0

48.19

38.10

ng/l

0.59

Inflammatory diseases of the central nervous system

177

2.45

6.91

1.1

1.0

39.80

43.11

ng/l

0.22

110

Mixed and other personality disorders

125

2.74

6.85

1.0

30.09

38.90

ng/l

0.93

Stroke, excluding SAH

262

1344

1.43

6.76

1.0

37.77

42.42

ng/l

1.11

168

918

Spondylosis

226

1264

1.46

6.74

1.0

36.86

43.59

ng/l

1.89

137

928

Influenza and pneumonia

384

1823

1.34

6.69

1.0

40.05

41.92

ng/l

0.14

268

1290

Colorectal cancer

751

0.39

6.68

1.0

36.74

44.82

ng/l

0.69

491

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

9.20

6.67

1.0

27.29

44.55

ng/l

—

Periodontitis

383

1919

1.34

6.59

1.0

39.29

42.21

ng/l

0.69

268

1343

Hypertensive diseases

302

1228

1.39

6.47

1.0

36.34

42.77

ng/l

2.02

220

867

Hypertension

302

1228

1.39

6.47

1.0

36.34

42.77

ng/l

2.02

220

867

Cervical disc disorders

152

975

1.56

6.46

1.0

37.17

43.12

ng/l

1.46

105

722

Cardiodefibrillation

1152

0.51

6.45

1.0

32.48

42.71

ng/l

2.48

773

Insomnia

304

1611

1.38

6.43

1.0

33.77

42.94

ng/l

3.85

227

1127

Malignant neoplasm of bronchus and lung, including Hilmo

618

0.39

6.37

1.0

33.09

45.58

ng/l

2.49

400

Injuries to the thorax

178

1186

1.50

6.34

1.0

36.31

42.17

ng/l

1.63

117

812

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

269

2.09

6.28

1.0

33.85

42.02

ng/l

1.12

188

Retention of urine

154

814

1.56

6.26

1.0

42.05

42.74

ng/l

0.08

108

531

Chronic periodontitis, including avohilmo

380

1922

1.33

6.25

1.0

39.26

42.21

ng/l

0.69

265

1346

All kidney diseases

365

1877

1.33

6.15

1.0

38.98

41.98

ng/l

0.74

263

1310

Fracture of skull and facial bones

454

1.81

6.10

1.0

31.31

42.94

ng/l

2.96

316

Colorectal adenocarcinoma

632

0.36

6.09

1.0

33.53

44.66

ng/l

1.10

411

Acute and transient psychotic disorders

220

2.19

6.08

1.0

78.96

44.65

ng/l

0.45

145

Other bacterial diseases

378

1815

1.32

6.06

1.0

34.55

42.77

ng/l

4.19

255

1289

Type 2 diabetes, wide definition

338

1612

1.34

6.04

1.0

36.33

43.45

ng/l

2.52

236

1142

Diabetes medication

383

1720

1.32

6.04

1.0

36.00

42.92

ng/l

2.48

268

1214

Other and unspecified injuries of head

128

2.60

6.04

1.0

41.48

41.32

ng/l

0.01

Implicit fungal Sepsis

3.37

6.01

1.0

31.87

52.99

ng/l

1.42

Other bacterial diseases

366

1859

1.32

6.00

1.0

37.06

42.47

ng/l

1.99

250

1318

All pneumoniae

368

1860

1.32

5.98

1.0

40.87

41.75

ng/l

0.06

259

1312

Specific personality disorders

387

1.87

5.89

1.0

41.07

43.70

ng/l

0.12

276

Restless leg syndrome

318

1.96

5.85

1.0

36.73

45.09

ng/l

1.49

209

Other and unspecified polyneuropathies, also in other diseases

542

1.72

5.84

1.1

1.0

55.95

42.80

ng/l

0.26

356

All influenza

100

595

1.69

5.80

1.0

33.04

43.65

ng/l

2.67

406

Diseases of the ear and mastoid process

415

1599

1.30

5.78

1.0

45.10

40.44

ng/l

0.43

289

1134

Disturbances of smell and taste

4.90

5.74

1.1

1.0

36.22

36.78

ng/l

—

Endocrine, nutritional and metabolic diseases

263

955

1.40

5.73

1.0

39.06

44.05

ng/l

1.20

183

687

Other lack of coordination

5.66

5.71

1.2

1.0

30.00

31.92

ng/l

—

253

2.06

5.68

1.0

32.07

49.24

ng/l

4.22

164

Phobic anxiety disorders

126

2.54

5.67

1.0

37.04

46.26

ng/l

0.47

Caries of dentine, including avohilmo

307

1158

1.36

5.62

1.0

43.75

42.30

ng/l

0.18

209

793

Sequelae of injuries, of poisoning and of other consequences of external causes

556

1.70

5.60

1.0

37.04

41.85

ng/l

0.65

392

COPD, hospital admissions

1253

0.60

5.53

1.0

39.98

43.02

ng/l

0.31

836

Alcohol dependence

112

696

1.61

5.52

1.0

42.12

40.93

ng/l

0.13

482

Diplopia

311

1.94

5.52

1.0

32.45

44.47

ng/l

2.43

209

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

360

1876

1.31

5.50

1.0

41.39

41.62

ng/l

0.01

254

1323

Later onset COPD

694

0.48

5.48

1.1

1.0

34.98

45.79

ng/l

1.29

424

Genitourinary diseases

208

723

1.44

5.47

1.0

40.79

41.19

ng/l

0.04

140

503

Symptoms and signs concerning food and fluid intake

204

2.16

5.43

1.0

54.80

45.10

ng/l

0.30

135

Pneumonias (Asthma/COPD co-morbidities)

363

1868

1.31

5.42

1.0

41.24

41.70

ng/l

0.03

255

1318

Dental caries, including avohilmo

293

1107

1.36

5.38

1.0

45.22

42.74

ng/l

0.31

198

754

Diseases of male genital organs

192

665

1.46

5.34

1.0

36.22

39.70

ng/l

0.64

140

451

Dementia due to Parkinson's disease

3.33

5.33

1.1

1.0

33.07

41.78

ng/l

0.52

Injuries to the shoulder and upper arm

319

1948

1.32

5.32

1.0

47.66

41.01

ng/l

0.49

224

1361

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

367

1.83

5.32

1.0

68.18

43.43

ng/l

0.40

255

Heart failure, strict

134

1427

0.66

5.32

1.0

34.94

42.61

ng/l

2.67

100

943

Dystonia

107

2.64

5.31

1.1

1.0

30.78

48.80

ng/l

2.36

COPD, early/later onset

1264

0.61

5.26

1.0

39.51

43.14

ng/l

0.41

844

COPD related to multimorbidity

1065

0.58

5.26

1.1

1.0

33.54

44.19

ng/l

2.16

699

All-cause Heart Failure

133

1415

0.66

5.24

1.0

35.00

42.67

ng/l

2.63

935

Pneumonia, organism unspecified

335

1792

1.31

5.22

1.0

42.68

42.18

ng/l

0.03

230

1263

Status epilepticus

3.15

5.20

1.0

35.20

41.60

ng/l

0.28

Hypertensive diseases (excluding secondary)

175

694

1.47

5.17

1.0

34.07

43.94

ng/l

2.80

124

517

Fracture at wrist and hand level

120

771

1.56

5.11

1.0

37.11

42.13

ng/l

1.02

528

Diseases of the myoneural junction and muscle

299

1.92

5.09

1.0

34.82

43.84

ng/l

1.16

196

Other problems related to primary support group, including family circumstances

118

2.48

5.06

1.0

95.23

45.05

ng/l

0.41

Ischaemic Stroke, excluding all haemorrhages

236

1282

1.37

5.03

1.0

36.61

42.77

ng/l

1.64

155

865

COPD, hospital admissions 3, with asthma pneumonia sepsis

697

0.49

5.03

1.1

1.0

40.41

43.99

ng/l

0.24

449

Vascular syndromes of brain in cerebrovascular disorders

3.30

5.03

1.1

1.0

39.90

29.77

ng/l

—

Cystitis

296

1323

1.33

5.01

1.0

46.34

42.90

ng/l

0.21

211

908

Cervicocranial syndrome

225

2.05

5.00

1.0

32.19

46.97

ng/l

1.69

164

Fungal Sepsis

2.98

4.99

1.0

31.87

52.85

ng/l

1.56

Soft tissue disorders

346

1365

1.31

4.98

1.0

39.83

42.98

ng/l

0.56

233

953

COPD, hospital admissions 1, only main diagnosis

910

0.55

4.98

1.1

1.0

45.61

43.23

ng/l

0.17

598

Transport accidents

149

867

1.48

4.95

1.0

37.03

40.45

ng/l

0.53

106

589

Continuous positive airway pressure

374

1.74

4.94

1.0

49.78

43.76

ng/l

0.61

269

Fracture of rib(s), sternum and thoracic spine

124

812

1.53

4.93

1.0

36.89

43.12

ng/l

1.26

553

Biguanides

370

1754

1.29

4.92

1.0

35.69

43.10

ng/l

2.67

254

1243

Migraine

138

747

1.50

4.85

1.0

33.18

44.66

ng/l

2.35

538

Other diseases of hard tissues of teeth

229

857

1.38

4.84

1.0

44.94

41.37

ng/l

0.56

158

588

Hypersomnia

5.30

4.79

1.1

1.0

32.76

40.43

ng/l

—

Volume depletion

202

2.09

4.79

1.0

28.78

47.00

ng/l

3.15

126

Explicit Sepsis

125

772

1.51

4.70

1.0

37.95

45.79

ng/l

1.82

475

Visual disturbances and blindness

190

1365

1.39

4.67

1.0

38.94

43.44

ng/l

0.83

135

929

Exposure to unspecified factor

350

1967

1.28

4.65

1.0

39.54

42.08

ng/l

0.53

270

1350

Visual disturbances

176

1250

1.41

4.64

1.0

37.08

43.36

ng/l

1.40

126

853

Diseases of the musculoskeletal system and connective tissue

162

556

1.46

4.63

1.0

40.53

43.35

ng/l

0.32

104

402

Other (not insulin) diabetes medications

369

1717

1.28

4.61

1.0

35.37

42.97

ng/l

2.79

256

1213

Hypothyroidism, drug reimbursement

109

2.27

4.59

1.0

44.55

50.27

ng/l

0.21

Other chronic obstructive pulmonary disease

1193

0.63

4.56

1.0

39.51

42.70

ng/l

0.35

795

Hypothyroidism, strict autoimmune, 3 medication purchases required

297

1536

1.31

4.56

1.0

46.83

42.06

ng/l

0.25

185

1084

Disorders of eyelid, lacrimal system and orbit

318

1871

1.29

4.55

1.0

38.75

42.93

ng/l

0.92

217

1303

Lung cancer and mesothelioma

545

0.45

4.53

1.0

33.09

46.49

ng/l

2.73

362

COPD

1238

0.65

4.48

1.0

38.71

42.74

ng/l

0.50

826

Systemic atrophies primarily affecting the central nervous system

2.60

4.48

1.1

1.0

29.21

45.54

ng/l

1.39

Migraine with aura

357

1.77

4.45

1.0

27.39

44.70

ng/l

5.66

248

Hard cardiovascular diseases

343

1599

1.28

4.42

1.0

38.40

42.44

ng/l

0.89

233

1157

Other and unspecified myopathies

202

2.04

4.42

1.0

40.24

43.63

ng/l

0.23

126

Malignant neoplasm of colon, including Hilmo

600

0.45

4.42

1.0

43.47

45.09

ng/l

0.06

386

Abnormalities of breathing

296

1319

1.30

4.39

1.0

35.19

43.98

ng/l

2.74

205

913

Emotionally unstable personality disorder

137

2.27

4.37

1.0

30.19

41.88

ng/l

1.26

Hypoglycaemia, other or unspecified

125

2.33

4.33

1.1

1.0

43.55

43.32

ng/l

0.01

Polyneuropathies and other disorders of the peripheral nervous system

613

1.57

4.33

1.1

1.0

55.22

41.88

ng/l

0.28

407

Malignant neoplasm of colon

453

0.37

4.31

1.0

42.22

46.21

ng/l

—

286

COPD, hospital admission 2, with asthma infections

828

0.57

4.30

1.1

1.0

41.26

43.74

ng/l

0.16

543

Hypothyreosis and Thyroxine purchase for inclusion criteria

325

1666

1.28

4.29

1.0

46.37

42.09

ng/l

0.26

210

1169

Diarrhoea and gastroenteritis of presumed infectious origin

230

1554

1.33

4.28

1.0

37.69

42.03

ng/l

0.98

169

1057

Other chronic obstructive pulmonary disease, including avohilmo

124

1495

0.68

4.28

1.0

39.12

43.34

ng/l

0.55

1003

Schizophrenia

325

1.79

4.27

1.0

32.71

44.92

ng/l

3.10

231

Oter anti-inflammatory and antirheumatic agents, non-steroids

301

1.64

4.27

1.0

35.24

44.64

ng/l

1.67

210

Persons encountering health services for other counselling and medical advice, not elsewhere classified

397

1722

1.25

4.26

1.0

34.01

43.17

ng/l

6.28

304

1162

Non-small cell lung cancer, including Hilmo

465

0.40

4.25

1.0

36.93

45.98

ng/l

1.00

296

Fracture of neck

139

2.25

4.25

1.1

1.0

42.55

42.84

ng/l

0.01

Disorders of ocular muscles, binocular movement, accommodation and refraction

148

1028

1.43

4.24

1.0

41.43

41.70

ng/l

0.03

721

Heart failure,strict

129

1319

0.69

4.24

1.0

34.76

42.35

ng/l

2.60

891

Certain infectious and parasitic diseases

277

1057

1.31

4.22

1.0

40.14

44.77

ng/l

0.80

187

747

Symptoms and signs involving the digestive system and abdomen

359

1418

1.27

4.22

1.0

41.96

41.92

ng/l

0.01

248

996

Disorders of lens

296

1429

1.29

4.21

1.0

40.81

43.33

ng/l

0.39

212

1022

Cervicobrachial syndrome

516

1.61

4.19

1.0

26.46

43.11

ng/l

7.20

386

Fall involving bed

2.93

4.18

1.1

1.0

37.40

40.56

ng/l

—

Migraine without aura and triptan purchases

187

2.04

4.12

1.0

32.46

42.76

ng/l

1.14

131

Injuries to the abdomen, lower back, lumbar spine and pelvis

136

934

1.44

4.11

1.0

57.00

42.37

ng/l

0.41

636

Bacterial infection, other or unspecified

211

1365

1.34

4.11

1.0

38.52

43.50

ng/l

1.08

145

934

Diseases of pulp and periapical tissues and dental caries

257

1000

1.32

4.04

1.0

47.07

43.04

ng/l

0.52

167

677

Other/unspecified dorsalgia

126

859

1.46

4.02

1.0

31.92

43.25

ng/l

4.74

630

Pain (limb, back, neck, head abdominally)

253

962

1.32

3.99

1.0

41.82

42.77

ng/l

0.12

169

691

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

101

1194

0.67

3.95

1.0

42.26

42.62

ng/l

0.03

841

Other disorders of fluid, electrolyte and acid-base balance

125

820

1.46

3.94

1.0

31.15

45.89

ng/l

5.93

538

Gastro-oesophageal reflux disease

260

1734

1.30

3.93

1.0

47.23

41.38

ng/l

0.33

180

1207

Injury, poisoning and certain other consequences of external causes

174

627

1.39

3.89

1.0

43.31

42.69

ng/l

0.07

116

444

Injuries to the wrist and hand

349

1933

1.25

3.88

1.0

39.00

42.00

ng/l

0.59

267

1334

Cramp and spasm

2.52

3.88

1.1

1.0

44.09

43.85

ng/l

0.01

Bacterial infection, other or unspecified

226

1452

1.32

3.87

1.0

38.52

44.02

ng/l

1.30

154

1001

Pain in joint

200

946

1.35

3.86

1.0

46.28

42.56

ng/l

0.16

150

686

Somatoform disorder

307

1.76

3.83

1.0

35.72

46.67

ng/l

1.59

206

Hypothyroidism, strict autoimmune

262

1332

1.30

3.82

1.0

39.97

42.71

ng/l

0.33

164

935

Special screening examination for infectious and parasitic diseases

186

1.86

3.78

1.0

36.48

40.17

ng/l

0.39

153

Injuries to the elbow and forearm

240

1624

1.30

3.77

1.0

41.73

42.33

ng/l

0.08

165

1131

Disorders of choroid and retina

317

1790

1.26

3.76

1.0

39.91

43.16

ng/l

0.65

225

1238

Used for control exclusion in common control thyroid runs

365

1481

1.25

3.72

1.0

36.98

42.08

ng/l

1.58

241

1053

Postmenopausal osteoporosis with pathological fracture

136

2.15

3.61

1.0

32.41

50.51

ng/l

2.05

Diverticular disease of intestine

292

1474

1.27

3.58

1.0

39.77

41.85

ng/l

0.38

196

1033

Primary hyperparathyroidism

277

1.78

3.58

1.1

1.0

33.20

46.62

ng/l

1.85

178

Pedestrian injured in transport accident

130

2.17

3.57

1.0

39.99

43.73

ng/l

0.17

Hypothyroidism, other/unspecified

307

1608

1.26

3.55

1.0

39.88

42.26

ng/l

0.34

198

1132

Other diseases of pleura

1225

0.68

3.52

1.0

39.37

42.76

ng/l

0.44

817

Colon adenocarcinoma

353

0.37

3.51

1.0

36.13

47.16

ng/l

—

215

Any event in cancer register

227

1723

0.77

3.47

1.0

34.78

43.11

ng/l

3.18

163

1208

Diabetes mellitus

354

1676

1.24

3.47

1.0

35.84

43.21

ng/l

2.61

247

1183

Senile cataract

279

1350

1.27

3.45

1.0

42.55

43.99

ng/l

0.18

197

961

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

344

1676

1.24

3.44

1.0

35.19

43.22

ng/l

3.06

240

1183

Pain, not elsewhere classified

543

1.53

3.44

1.0

34.82

44.18

ng/l

2.09

386

314

1525

1.25

3.39

1.0

41.76

42.84

ng/l

0.06

219

1072

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

314

1525

1.25

3.39

1.0

41.76

42.84

ng/l

0.06

219

1072

Fibromyalgia

140

2.08

3.37

1.0

28.50

47.25

ng/l

2.97

Other specified/unspecified disorders of bone/cartilage

2.86

3.36

1.0

40.30

31.07

ng/l

—

Hernia

335

1819

1.24

3.36

1.0

42.95

41.28

ng/l

0.10

222

1292

Diabetes, varying definitions

352

1678

1.23

3.34

1.0

35.73

43.20

ng/l

2.66

246

1184

Dipeptidyl peptidase 4 (DPP-4) inhibitors

231

1442

1.28

3.32

1.0

40.52

45.12

ng/l

0.64

152

994

Fall on same level involving ice and snow

203

1563

1.30

3.30

1.0

43.02

43.19

ng/l

0.01

133

1084

Disorders of the thyroid gland

326

1720

1.24

3.27

1.0

39.36

42.11

ng/l

0.43

212

1218

Later onset COPD, excluding more controls

545

0.57

3.27

1.1

1.0

31.58

47.05

ng/l

2.67

347

Nontraumatic intracranial haemmorrhage

487

1.54

3.24

1.0

41.61

44.49

ng/l

0.21

320

Hypo-osmolality and hyponatraemia

461

1.56

3.23

1.0

29.27

46.99

ng/l

9.07

303

Renal tubulo-interstitial diseases

307

1847

1.24

3.23

1.0

39.16

42.93

ng/l

1.01

217

1275

Cardiovascular diseases (excluding rheumatic etc)

164

698

1.35

3.23

1.0

38.59

43.89

ng/l

0.89

110

519

Type 2 diabetes

351

1674

1.23

3.23

1.0

34.83

43.23

ng/l

3.37

243

1182

Unspecified urinary incontinence

206

1.85

3.21

1.0

57.85

43.45

ng/l

0.42

129

Diseases of the eye and adnexa

254

999

1.27

3.20

1.0

40.44

42.17

ng/l

0.22

186

741

Meningitis

2.28

3.19

1.1

1.0

34.59

40.23

ng/l

0.25

Diabetes, insulin treatment (Kela reimbursement)

364

1808

1.22

3.15

1.0

35.64

42.76

ng/l

2.69

254

1272

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

3.13

0.0

1.0

—

43.58

—

Fissure and fistula of anal and rectal regions

621

1.47

3.12

1.0

36.19

43.96

ng/l

1.24

430

Other disorders of nervous system

131

2.07

3.12

1.0

35.99

44.75

ng/l

0.60

Anomalies of pupillary function

3.70

3.09

1.0

23.83

37.84

ng/l

—

Fracture of forearm

191

1350

1.30

3.05

1.0

43.12

43.46

ng/l

0.04

132

938

Voice disturbances

658

1.45

3.03

1.0

59.87

43.80

ng/l

0.43

441

Oedema, not elsewhere classified

104

724

1.42

2.99

1.0

37.14

44.43

ng/l

1.59

499

Gingivitis and periodontal diseases

361

1536

1.21

2.97

1.0

41.99

42.40

ng/l

0.05

244

1072

Peripheral arterial reconstruction

463

0.50

2.97

1.0

41.39

43.89

ng/l

0.21

289

Oxycodone

1145

0.69

2.97

1.0

34.15

43.59

ng/l

2.26

776

Eating disorders

2.24

2.95

1.0

40.93

42.11

ng/l

0.04

Other disorders of glucose regulation and pancreatic internal secretion

162

1.92

2.94

1.1

1.0

43.18

43.81

ng/l

0.02

101

Other fall from one level to another

499

1.51

2.93

1.0

38.43

42.68

ng/l

0.34

338

Acute tubulo-interstitial nephritis

220

1500

1.27

2.91

1.0

39.31

43.87

ng/l

1.08

155

1013

Bacterial meningitis

2.52

2.87

1.1

1.0

38.50

44.55

ng/l

—

Solid cancers, helper endpoint

226

1676

0.80

2.87

1.0

34.25

42.67

ng/l

3.24

158

1182

Psoriasis

749

0.61

2.84

1.0

39.65

42.31

ng/l

0.15

524

Other general symptoms and signs

2.57

2.82

1.0

30.10

41.48

ng/l

—

Acute alcohol intoxication

619

1.44

2.81

1.0

38.26

41.44

ng/l

0.32

426

Disorders of other endocrine glands

136

999

1.34

2.80

1.0

33.40

42.50

ng/l

2.72

101

672

Injury of muscle and tendon at shoulder and upper arm level

143

1077

1.33

2.80

1.0

46.03

41.65

ng/l

0.41

101

746

Certain infectious and parasitic diseases

335

1384

1.21

2.77

1.0

37.22

43.65

ng/l

1.96

231

969

Basal cell carcinoma, including avohilmo

131

1204

0.75

2.74

1.1

1.0

37.88

45.60

ng/l

1.39

813

Symptoms and signs involving the circulatory and respiratory systems

320

1319

1.22

2.72

1.0

36.41

43.98

ng/l

2.11

227

913

Other intracranial haemorrhages

2.44

2.71

1.1

1.0

26.80

42.29

ng/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

763

0.67

2.71

1.0

45.98

42.92

ng/l

0.18

557

Polyuria

599

1.44

2.71

1.0

45.62

43.38

ng/l

0.22

395

Insulin, intermediate and long-acting

195

1494

1.27

2.70

1.0

38.03

42.04

ng/l

0.78

133

1020

Disorders of parathyroid gland

511

1.47

2.69

1.0

33.12

45.91

ng/l

2.76

336

Other disorders of penis

204

1.77

2.68

1.1

1.0

51.97

40.39

ng/l

0.91

133

Complications of other internal prosthetic devices, implants and grafts

2.19

2.67

1.0

52.08

46.30

ng/l

—

Gout, strict definition

548

0.56

2.66

1.0

32.88

42.15

ng/l

0.98

356

Carcinoma in situ of skin

214

0.37

2.66

1.1

1.0

52.50

45.60

ng/l

—

132

Injuries to the hip and thigh

166

1163

1.29

2.66

1.0

49.89

42.76

ng/l

0.77

105

778

Exclusions for E4_PCOS_BROAD

342

1.58

2.66

1.0

33.59

43.80

ng/l

1.53

230

Diseases of tongue

126

1.99

2.65

1.0

28.60

46.53

ng/l

2.07

3.17

2.65

1.0

29.40

43.26

ng/l

—

Inguinal hernia

208

1102

1.26

2.63

1.0

35.47

41.52

ng/l

1.66

133

769

Redundant prepuce, phimosis and paraphimosis

411

1.52

2.61

1.0

42.52

39.57

ng/l

0.12

274

Endovascular or surgical operations to intracerebral aneurysms

155

1.88

2.61

1.1

1.0

51.43

46.37

ng/l

0.16

Cardiomyopathy

557

0.57

2.61

1.0

34.57

41.76

ng/l

0.63

368

Fracture of lumbar spine and pelvis

537

1.45

2.60

1.0

74.70

44.63

ng/l

0.49

348

Strabismus

545

1.45

2.59

1.0

39.02

43.19

ng/l

0.37

379

Diabetic retinopathy, excluding more controls

333

1.45

2.59

1.0

30.21

39.77

ng/l

2.02

229

Exclusions for E4_PCOS_CONSORTIUM

210

1045

1.26

2.58

1.0

38.87

42.58

ng/l

0.60

159

730

Abdominal and pelvic pain

339

1418

1.20

2.57

1.0

40.79

41.92

ng/l

0.16

239

996

Superficial injury of abdomen, lower back and pelvis

306

1.61

2.57

1.0

32.07

43.23

ng/l

1.69

205

Migraine with aura and triptan purchases

192

1.77

2.57

1.0

27.55

42.23

ng/l

2.98

133

Unstable angina pectoris

981

0.71

2.57

1.0

31.17

44.16

ng/l

4.32

668

Cardiovascular diseases

140

565

1.33

2.56

1.0

39.46

43.23

ng/l

0.45

427

Acute alcohol intoxication, ICD10

466

1.48

2.56

1.0

35.87

42.11

ng/l

0.73

326

Hyperparathyroidism

445

1.49

2.55

1.0

34.24

46.53

ng/l

2.23

287

Finngen Rheumatological endpoints

323

1528

1.20

2.54

1.0

39.10

42.86

ng/l

0.80

225

1082

Atherosclerosis, excluding cerebral and coronary sclerosis

1056

0.73

2.54

1.0

41.05

43.89

ng/l

0.36

693

Injuries to the neck

459

1.48

2.53

1.0

36.89

42.07

ng/l

0.60

325

Early lumbar disc prolapse, operated

101

2.08

2.52

1.0

34.44

37.53

ng/l

0.13

Impingement syndrome of shoulder

100

726

1.38

2.52

1.0

40.81

42.15

ng/l

0.14

508

Disorders of vestibular function (Vertigo)

173

1338

1.27

2.49

1.0

41.52

43.38

ng/l

0.23

115

919

Other ill-defined and unspecified causes of mortality

180

1.79

2.47

1.0

39.88

44.32

ng/l

0.22

108

Viral and other specified intestinal infections

264

1.63

2.46

1.1

1.0

41.27

42.59

ng/l

0.08

170

Amyloidosis, other/unspecified

2.70

2.46

1.1

1.0

43.58

42.84

ng/l

0.02

Irritable bowel syndrome

620

1.41

2.45

1.0

43.07

43.79

ng/l

0.06

423

Paracetamol or NSAID medication

132

1.68

2.45

1.0

32.00

48.64

ng/l

2.35

Subjective visual disturbances

604

1.41

2.43

1.0

40.04

44.12

ng/l

0.54

418

Hepatocellular carcinoma

0.00

2.43

0.0

1.0

—

45.67

—

Other disorders of eye and adnexa

288

1.60

2.41

1.0

34.62

44.94

ng/l

1.16

186

Disorders of synovium and tendon

178

1235

1.26

2.39

1.0

45.27

43.38

ng/l

0.20

136

874

Excessive earwax

197

1544

1.25

2.38

1.0

43.68

42.18

ng/l

0.13

119

1057

Type 2 diabetes, definitions combined

338

1671

1.19

2.37

1.0

34.37

43.27

ng/l

3.51

229

1180

Other heart diseases

139

694

1.31

2.36

1.0

39.99

43.94

ng/l

0.64

517

Intracerebral haemorrhage

298

1.58

2.35

1.0

45.71

45.77

ng/l

0.00

189

Missing teeth due to accident, extraction or parodontitis

231

1781

1.22

2.34

1.0

42.53

42.82

ng/l

0.03

142

1256

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

331

1816

1.19

2.34

1.0

38.92

42.02

ng/l

0.68

237

1277

Aortic aneurysm

686

0.64

2.34

1.0

42.28

42.98

ng/l

0.05

442

Fracture of femur

620

1.38

2.33

1.0

43.74

44.77

ng/l

0.08

401

Other disorders of lacrimal gland

122

926

1.32

2.33

1.0

40.72

45.22

ng/l

0.53

634

Allergic rhinitis

520

1.43

2.32

1.0

39.84

41.67

ng/l

0.16

360

Basal cell carcinoma

129

1162

0.77

2.32

1.1

1.0

37.98

45.75

ng/l

1.33

780

Colonic or urogenital fistula

687

1.37

2.30

1.0

37.62

42.11

ng/l

0.58

471

Type 2 diabetes, strict (exclude DM1)

338

1676

1.18

2.30

1.0

34.56

43.25

ng/l

3.36

230

1184

Calcific aortic valvular stenosis

815

0.68

2.30

1.0

46.56

43.63

ng/l

0.21

515

Calcific aortic valvular stenosis, operated

815

0.68

2.30

1.0

46.56

43.63

ng/l

0.21

515

Chronic apical periodontitis

372

1803

1.18

2.30

1.0

39.21

42.33

ng/l

0.69

256

1255

Operations 2 for CAVS

814

0.68

2.29

1.0

46.56

43.65

ng/l

0.21

514

Calcific aortic valvular stenosis, diagnosis (helper)

814

0.68

2.29

1.0

46.56

43.65

ng/l

0.21

514

Substance use, excluding alcohol

380

1.50

2.29

1.1

1.0

35.66

42.26

ng/l

0.96

273

Malignant neoplasm

233

1678

0.82

2.29

1.0

34.95

42.64

ng/l

2.65

167

1183

Neuromuscular dysfunction of bladder

200

1.71

2.28

1.1

1.0

32.17

42.80

ng/l

0.97

130

Gastrointestinal diseases

185

735

1.26

2.27

1.0

44.52

42.50

ng/l

0.23

117

515

Malignant neoplasm of small intestine

0.00

2.25

0.0

1.0

—

41.37

—

Other disorders starting during childhood or adolescence

4.58

2.25

1.0

28.57

41.13

ng/l

—

Non-ischemic cardiomyopathy

816

0.71

2.23

1.0

38.01

45.07

ng/l

1.13

540

Weight loss

240

1.63

2.22

1.1

1.0

56.48

43.89

ng/l

0.37

153

Calcific aortic valvular stenosis, including rheumatic fever

819

0.68

2.22

1.0

46.44

43.70

ng/l

0.20

515

COPD (mode)

814

0.71

2.21

1.0

39.69

44.72

ng/l

0.55

543

Malignant neoplasm of prostate, including Hilmo

701

0.73

2.21

1.0

36.02

41.22

ng/l

0.73

481

Nausea and vomiting

587

1.39

2.20

1.0

46.15

42.87

ng/l

0.17

385

Osteoporosis

655

1.36

2.19

1.0

36.35

45.95

ng/l

1.88

432

Gout, unspecified

615

0.63

2.19

1.0

40.63

42.05

ng/l

0.09

404

Cardiomyopathy (excluding other)

402

0.55

2.18

1.0

35.06

42.07

ng/l

0.40

263

Other specific joint derangements/joint disorders

227

1202

1.22

2.18

1.0

46.28

41.38

ng/l

0.24

164

848

Tonsillectomy and adenotomy

680

0.71

2.18

1.0

34.68

38.39

ng/l

0.55

497

Alcohol abuse, main dg

352

1.51

2.18

1.0

37.32

41.54

ng/l

0.39

248

Anorexia (incl.atypical)

2.51

2.18

1.1

1.0

26.00

38.51

ng/l

—

Pain in thoracic spine

304

1.55

2.18

1.0

30.01

43.96

ng/l

2.14

226

Pleural effusion

440

0.57

2.18

1.0

44.51

44.72

ng/l

0.01

278

Primary gonarthrosis, bilateral

140

1525

0.78

2.16

1.0

39.32

43.71

ng/l

0.80

1053

Mixed conductive and sensorineural hearing loss

321

1.53

2.15

1.0

42.49

43.75

ng/l

0.09

219

Assault by bodily force

2.03

2.15

1.1

1.0

34.79

32.33

ng/l

0.18

Early lumbar disc prolapse operation

122

1.89

2.15

1.0

32.99

38.50

ng/l

0.30

In situ neoplasms

1016

0.72

2.15

1.0

44.45

43.47

ng/l

0.08

670

Valvular operations

463

0.58

2.14

1.0

50.30

42.74

ng/l

0.49

305

Fall on and from stairs and steps

637

1.37

2.13

1.0

39.92

43.28

ng/l

0.42

441

Abnormal findings on diagnostic imaging of other body structures

373

0.53

2.13

1.0

28.69

46.27

ng/l

2.58

247

Benign neoplasm: Cerebral meninges

235

1.62

2.13

1.0

33.74

45.47

ng/l

1.39

146

Non-rheumatic valve diseases

131

1210

0.78

2.11

1.0

43.37

42.34

ng/l

0.11

834

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.62

2.11

1.0

26.49

37.41

ng/l

—

Diseases of inner ear

198

1563

1.23

2.11

1.0

43.93

42.69

ng/l

0.15

133

1079

Rheumatism, unspecified

331

1.51

2.10

1.0

37.92

44.95

ng/l

0.64

224

Retinal detachments and breaks

134

1047

1.28

2.10

1.0

44.47

42.30

ng/l

0.23

102

699

Other gastritis (incl. Duodenitis)

606

1.37

2.08

1.0

42.57

43.20

ng/l

0.06

409

Other cataract

175

1066

1.24

2.07

1.0

43.85

44.77

ng/l

0.09

120

743

Presbyopia

146

1.79

2.06

1.0

39.16

43.25

ng/l

0.16

Other postsurgical states

154

1.76

2.04

1.0

26.60

44.69

ng/l

—

Cough

141

1053

1.27

2.03

1.0

43.55

45.67

ng/l

0.21

110

719

Intestinal infectious diseases

388

1915

1.16

2.03

1.0

39.50

42.27

ng/l

0.62

286

1323

Abnormal findings on diagnostic imaging of lung

121

1485

0.78

2.02

1.0

39.43

44.38

ng/l

0.65

987

Autoimmune diseases

364

1591

1.16

2.01

1.0

37.88

41.65

ng/l

1.00

239

1132

Benign neoplasm of brain and other parts of central nervous system

140

1.79

2.01

1.1

1.0

44.08

45.49

ng/l

0.06

Abnormal blood-pressure reading, without diagnosis

104

1.93

2.00

1.1

1.0

29.00

46.69

ng/l

—

Cardiomyopathies, Primary/intrinsic

390

0.56

1.99

1.0

35.06

41.84

ng/l

0.39

256

Malignant neoplasm of prostate

679

0.74

1.99

1.0

35.87

41.56

ng/l

0.82

466

Any reimbursement code in KELA

158

628

1.26

1.99

1.0

36.28

42.27

ng/l

1.01

105

462

Malignant neoplasm of skin

153

1308

0.80

1.99

1.1

1.0

35.62

44.57

ng/l

2.09

103

895

Peripheral artery disease

108

1116

0.77

1.98

1.0

39.82

43.54

ng/l

0.55

734

Other respiratory diseases principally affecting the interstitium

501

0.62

1.97

1.0

32.25

44.03

ng/l

0.86

323

Psoriatic arthropathies

244

0.45

1.97

1.0

19.83

45.43

ng/l

—

173

Actinic keratosis

1073

0.75

1.96

1.0

42.05

44.81

ng/l

0.27

689

Abnormal weight loss

225

1.61

1.96

1.1

1.0

55.35

42.82

ng/l

0.35

142

Bronchitis, not specified as acute or chronic

194

1.65

1.96

1.1

1.0

55.33

42.77

ng/l

0.43

120

Tramadol

277

1439

1.18

1.94

1.0

35.92

42.97

ng/l

2.77

200

995

Valvular heart disease excluding rheumatic fever

133

1212

0.79

1.94

1.0

43.05

42.34

ng/l

0.08

835

Benign paroxysmal vertigo

102

779

1.31

1.93

1.1

1.0

38.36

43.93

ng/l

0.91

530

Gonarthrosis, primary, with knee surgery

167

1632

0.81

1.91

1.0

45.78

42.88

ng/l

0.38

1131

Ocular pain

150

1.74

1.90

1.1

1.0

31.10

46.70

ng/l

1.55

Colectomy operation

459

0.61

1.90

1.0

47.56

43.22

ng/l

0.21

307

Asthma (mode)

262

1181

1.19

1.90

1.0

46.20

42.73

ng/l

0.18

181

820

Persons encountering health services in other circumstances

121

943

1.28

1.89

1.0

55.22

44.24

ng/l

0.34

623

Autoimmune diseases excluding thyroid diseases, strict definition

330

1552

1.16

1.89

1.0

37.17

41.73

ng/l

1.69

239

1102

Secondary malignant neoplasm of other and unspecified sites

0.00

1.89

0.0

1.0

—

47.60

—

Superficial injury of lower leg

532

1.37

1.88

1.0

36.71

44.02

ng/l

1.05

371

Type 2 diabetes, definitions combined, including avohilmo

330

1652

1.16

1.88

1.0

34.14

43.39

ng/l

3.74

227

1165

Asthma and allergy, excluding more controls

186

1.65

1.88

1.1

1.0

35.00

47.42

ng/l

1.12

126

752

0.72

1.87

1.1

1.0

40.47

45.94

ng/l

0.57

475

Type of accident

670

1.33

1.87

1.0

46.15

42.93

ng/l

0.26

458

Benign neoplasm of meninges

260

1.54

1.86

1.0

33.25

46.38

ng/l

1.74

164

Viral and other specified intestinal infections

368

1.44

1.86

1.1

1.0

40.35

41.79

ng/l

0.10

244

Malignant neoplasm of breast, HER2-negative

822

0.76

1.86

1.0

41.44

46.43

ng/l

0.56

581

Insulin medication

202

1409

1.21

1.85

1.0

38.20

43.94

ng/l

1.15

137

974

Pneumonitis due to solids and liquids

190

1.64

1.84

1.0

44.03

42.95

ng/l

0.05

117

Paralytic strabismus

167

1.68

1.84

1.0

29.94

46.76

ng/l

1.62

101

Malignant melanoma, including Hilmo

539

0.65

1.82

1.0

32.63

45.80

ng/l

1.69

355

Ill-defined and unknown causes of mortality

214

1.59

1.82

1.0

37.43

44.65

ng/l

0.45

130

Malignant melanoma

453

0.62

1.81

1.0

34.00

45.29

ng/l

1.11

292

Drug-induced neutropenia

182

0.44

1.81

1.0

58.00

45.59

ng/l

—

115

Periapical abscess

152

1231

1.24

1.81

1.0

37.83

40.51

ng/l

0.36

112

864

Psoriasis vulgaris

477

0.63

1.80

1.0

34.78

42.87

ng/l

0.54

339

Use of disulfiram, acamprosate or naltrexone

199

1.61

1.80

1.0

31.56

40.24

ng/l

1.14

136

Bacterial, viral and other infectious agents

153

1.70

1.79

1.0

40.94

37.81

ng/l

0.16

100

malignant neoplasm of male genital organs

692

0.76

1.78

1.0

36.03

41.37

ng/l

0.78

474

Malignant neoplasm, wide definition for exclusion

243

1682

0.85

1.78

1.0

36.40

42.61

ng/l

1.77

171

1186

Postpartum haemorrhage

264

0.54

1.78

1.0

59.81

38.62

ng/l

0.42

205

Vasomotor and allergic rhinitis

103

783

1.29

1.77

1.0

38.61

42.62

ng/l

0.43

554

Cardiac arrhythmias

176

937

1.22

1.77

1.0

40.10

43.83

ng/l

0.50

124

689

Coronary artery bypass grafting

646

0.72

1.76

1.0

40.41

43.94

ng/l

0.38

432

Fibroblastic disorders

608

1.33

1.75

1.0

40.29

43.29

ng/l

0.35

417

Supplementary factors related to causes of morbidity and mortality classified elsewhere

721

1.31

1.75

1.0

44.74

42.46

ng/l

0.19

495

malignant neoplasm of female genital organs

421

0.61

1.74

1.1

1.0

36.16

47.77

ng/l

1.62

278

Other malignant neoplasms of skin (=non-melanoma skin cancer)

141

1196

0.81

1.74

1.1

1.0

36.90

45.35

ng/l

1.70

807

Gout, idiopatic and unspecified

745

0.71

1.73

1.0

39.03

42.27

ng/l

0.31

498

Other disorders of the musculoskeletal system and connective tissue

380

1.42

1.73

1.1

1.0

34.46

43.75

ng/l

1.20

259

Autoimmune diseases excluding thyroid diseases

336

1590

1.15

1.72

1.0

37.14

41.65

ng/l

1.72

243

1132

Asthma and allergy

191

1.60

1.72

1.1

1.0

35.00

47.52

ng/l

1.14

129

Asthma

264

1178

1.18

1.71

1.0

45.76

42.76

ng/l

0.15

184

818

Crowding of teeth, including avohilmo

0.00

1.71

0.0

1.0

—

35.32

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

153

1270

0.82

1.71

1.1

1.0

37.45

45.08

ng/l

1.56

863

Pain associated with micturition

274

1.50

1.71

1.0

34.31

43.65

ng/l

1.25

178

Budesonide

315

1.46

1.70

1.0

37.28

44.10

ng/l

0.55

221

Benign neoplasm of colon, rectum, anus and anal canal

244

1804

1.18

1.70

1.0

43.99

42.85

ng/l

0.13

172

1240

L02BG Aromatase inhibitors

879

0.74

1.69

1.0

39.89

46.44

ng/l

0.67

610

Pneumocystosis

0.00

1.69

0.0

1.0

—

35.36

—

Panic disorder

164

1.65

1.67

1.0

24.89

46.66

ng/l

4.65

108

Complications of surgical and medical care, not elsewhere classified

331

1974

1.15

1.67

1.0

39.57

42.05

ng/l

0.56

227

1386

Use of pramipexole

579

1.33

1.67

1.0

39.80

44.92

ng/l

0.65

393

Osteoporosis with pathological fracture (FG)

180

1.62

1.66

1.0

32.41

50.97

ng/l

2.31

117

Malignant neoplasm of breast, HER-positive

783

0.76

1.65

1.0

38.38

47.04

ng/l

1.13

549

Hemiplegia

1.90

1.65

1.1

1.0

27.83

46.10

ng/l

1.85

1156

0.78

1.64

1.0

40.89

44.63

ng/l

0.42

751

Hypertrophic disorders of skin

1.98

1.64

1.0

20.75

42.08

ng/l

—

Renal failure

109

1213

0.79

1.63

1.0

38.94

43.76

ng/l

0.69

800

Maternal care related to the fetus and amniotic cavity and possible delivery problems

510

0.74

1.63

1.0

34.57

40.89

ng/l

0.75

389

Hypertensive Heart Disease

605

0.72

1.62

1.0

39.10

46.19

ng/l

0.91

395

Cardiomyopathy, other and unspecified

251

0.52

1.62

1.0

32.87

44.42

ng/l

—

159

Osteopathies and chondropathies

190

1484

1.19

1.61

1.0

37.24

43.33

ng/l

1.34

127

1028

Malignant melanoma of skin, including Hilmo

450

0.64

1.60

1.0

30.25

45.28

ng/l

1.70

287

Carbimazole or st.post thyroidectomy, condition for graves disease

474

0.65

1.60

1.0

41.76

44.04

ng/l

0.13

324

Persons encountering health services for specific procedures, not carried out

151

1.66

1.59

1.0

31.59

47.72

ng/l

1.52

Type 1 diabetes

523

1.34

1.58

1.0

40.39

42.95

ng/l

0.23

363

Bacterial, viral and other infectious agents

160

1.63

1.55

1.0

40.94

37.91

ng/l

0.16

104

Malignant neoplasm of breast, ER-positive, including Hilmo

784

0.77

1.55

1.0

37.98

47.03

ng/l

1.22

550

Asthma, excluding more controls

254

1135

1.17

1.55

1.0

45.32

42.94

ng/l

0.11

178

792

Excessive vomiting in pregnancy

107

1.78

1.54

1.0

36.69

49.60

ng/l

0.86

Atrial fibrillation and flutter with reimbursement

568

0.75

1.54

1.0

40.96

46.60

ng/l

0.64

422

Diabetic neuropathy

239

1.50

1.53

1.1

1.0

32.95

35.99

ng/l

0.24

162

Heart failure and antihypertensive medication

516

0.73

1.53

1.0

37.67

42.69

ng/l

0.62

390

Malignant neoplasm of bladder, including Hilmo

357

0.61

1.53

1.0

47.71

44.84

ng/l

0.15

221

Viral pneumonia

298

1.45

1.52

1.0

29.30

45.43

ng/l

4.04

204

Malignant neoplasm of breast

100

824

0.79

1.52

1.0

41.66

46.41

ng/l

0.53

583

Oligomenorrhoea

0.00

1.52

0.0

1.0

—

66.34

—

Myocardial infarction, strict

131

1142

0.82

1.52

1.0

42.14

43.21

ng/l

0.12

789

Dysplasia of cervi uteri

323

0.65

1.52

1.0

40.00

44.82

ng/l

0.24

232

Lesion of sciatic nerve

1.84

1.51

1.0

30.69

43.67

ng/l

—

Papulosquamous disorders

1122

0.78

1.51

1.0

40.89

42.41

ng/l

0.13

781

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.00

1.50

0.0

1.0

—

46.97

—

1.86

1.49

1.0

40.13

50.90

ng/l

—

Abnormal spermatozoa

393

0.63

1.48

1.0

48.55

41.17

ng/l

0.24

260

Other and unspecified follicular disorders

2.01

1.48

1.0

41.75

42.48

ng/l

—

Postpartum hemorraghe, parous women as controls

251

0.58

1.48

1.0

59.81

39.97

ng/l

0.38

193

Other enthesopathies

785

1.26

1.48

1.0

39.50

44.71

ng/l

0.57

556

Medicines for HER+ breast cancer

975

0.78

1.47

1.1

1.0

39.70

45.49

ng/l

0.67

680

Hyperlipidaemia, other/unspecified

146

1111

1.21

1.47

1.0

40.77

44.33

ng/l

0.45

111

733

Early onset COPD

687

0.73

1.47

1.0

43.54

43.26

ng/l

0.02

469

Hypogonadotropic hypogonadism

2.23

1.46

1.0

21.00

25.69

ng/l

—

Radiculopathy

385

1.38

1.46

1.1

1.0

35.13

45.37

ng/l

1.83

274

Vocal cord dysfunction

247

1.46

1.0

47.69

48.63

ng/l

0.04

179

Coxarthrosis, primary, with hip surgery

126

1438

0.82

1.45

1.0

39.74

44.08

ng/l

0.59

967

Superficial injury of forearm

171

1.58

1.45

1.0

30.25

44.39

ng/l

1.91

111

Dialysis, with operation codes

354

0.62

1.45

1.0

43.41

43.79

ng/l

0.01

250

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

844

0.77

1.45

1.1

1.0

40.73

44.12

ng/l

0.34

615

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

567

1.31

1.44

1.0

38.32

42.02

ng/l

0.31

398

Insulin, combination of fast acting with intermediate-acting or long-acting

202

1574

1.17

1.44

1.0

38.20

42.20

ng/l

0.80

137

1073

Superficial injury of hip and thigh

327

1.41

1.44

1.0

62.22

42.58

ng/l

0.78

212

Small fibre neuropathy

1.98

1.43

1.1

1.0

19.71

44.52

ng/l

—

Hypertrophic scar

1.98

1.43

1.0

13.71

40.27

ng/l

—

Caries of dentine

493

1.32

1.43

1.0

47.66

41.32

ng/l

0.51

349

Propionic acid derivatives

303

1.31

1.43

1.0

42.42

44.34

ng/l

0.10

212

Myocardial infarction, with ST-elevation

473

0.68

1.43

1.0

49.05

42.83

ng/l

0.29

306

Psoriatic and enteropathic arthropathies

278

0.57

1.43

1.0

24.33

44.69

ng/l

—

200

Tongue abnormality

141

1.64

1.41

1.0

30.00

48.05

ng/l

1.78

Heart failure and bmi 25plus

655

0.77

1.41

1.0

31.51

41.70

ng/l

4.04

432

Inflammatory diseases of prostate (prostatitis)

312

1.41

1.40

1.1

1.0

41.12

41.83

ng/l

0.05

206

Disorders of sclera, cornea, iris and ciliary body

170

1435

1.19

1.40

1.0

40.37

42.06

ng/l

0.21

124

992

Other diseases of the respiratory system

541

0.70

1.39

1.1

1.0

32.38

43.58

ng/l

1.24

353

Other respiratory disorders and diseases

541

0.70

1.39

1.1

1.0

32.38

43.58

ng/l

1.24

353

Malignant neoplasm of breast, including Hilmo

103

829

0.80

1.39

1.0

41.47

46.36

ng/l

0.56

587

Malignant neoplasm of breast, HER2-negative, including Hilmo

103

829

0.80

1.39

1.0

41.47

46.36

ng/l

0.56

587

Glaucoma

206

1519

1.17

1.39

1.0

43.21

43.79

ng/l

0.07

129

1032

Candidiasis

650

1.28

1.39

1.0

37.22

44.15

ng/l

1.23

445

Disorders of skin appendages

132

1088

1.21

1.39

1.0

37.79

40.91

ng/l

0.47

765

Skin changes due to chronic exposure to nonionizing radiation

1094

0.80

1.38

1.0

41.82

44.74

ng/l

0.30

704

Other interstitial pulmonary diseases

421

0.66

1.37

1.0

32.06

44.36

ng/l

0.73

273

Ménière disease

231

1.48

1.36

1.0

42.91

45.48

ng/l

0.12

143

Drug-induced osteoporosis with pathological fracture

0.00

1.35

0.0

1.0

—

39.30

—

Interstitial lung disease

419

0.67

1.35

1.0

32.06

44.40

ng/l

0.73

272

Interstitial lung disease endpoints

419

0.67

1.35

1.0

32.06

44.40

ng/l

0.73

272

Aneurysms, operations, SAH

409

1.35

1.34

1.0

46.52

45.21

ng/l

0.07

276

Retinal detachment with retinal break

358

1.37

1.33

1.1

1.0

50.58

41.97

ng/l

0.53

238

Functional dyspepsia

663

1.27

1.33

1.0

35.26

43.43

ng/l

1.51

449

Laparoscopic left hemicolectomy

0.00

1.33

0.0

1.0

—

30.82

—

Reimbursement for rheumatic diseases

135

1610

0.83

1.32

1.0

41.64

42.33

ng/l

0.06

1125

Malignant neoplasm of head and neck

246

0.57

1.32

1.0

34.78

46.50

ng/l

—

150

Anti-inflammatory and antirheumatic products, non-steroids

303

1.30

1.31

1.0

36.37

44.34

ng/l

0.97

212

Appendectomy

141

1607

0.84

1.31

1.0

40.56

41.23

ng/l

0.08

103

1126

Tooth eruption problems

1.77

1.31

1.0

29.10

41.51

ng/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

487

0.70

1.31

1.0

31.22

44.10

ng/l

3.32

314

Anterior Iridocyclitis

480

1.31

1.0

38.83

43.86

ng/l

0.67

339

Ulcer of lower limb, not elsewhere classified

380

0.66

1.30

1.0

43.26

44.05

ng/l

0.05

248

First line medication for Crohn's disease

290

1777

0.88

1.30

1.0

38.39

40.96

ng/l

0.58

199

1250

Dilated cardiomyopathy

331

0.63

1.29

1.0

35.47

43.92

ng/l

0.47

222

Other/unspecified enthesopathies, not elsewhere classified

201

1.50

1.29

1.0

39.18

47.69

ng/l

0.71

137

Other noninfective gastroenteritis and colitis

533

1.30

1.29

1.0

30.48

44.72

ng/l

4.24

361

Assault

193

1.50

1.29

1.0

36.35

41.24

ng/l

0.46

132

Phakomatoses, not elsewhere classified

2.80

1.29

1.2

1.0

22.60

40.00

ng/l

—

Other strabismus

419

1.33

1.28

1.0

41.17

44.04

ng/l

0.19

293

Allergic asthma (mode)

437

1.32

1.28

1.0

41.41

44.47

ng/l

0.20

300

ILD, hospital admissions

414

0.67

1.28

1.0

32.06

44.60

ng/l

0.75

269

Other disorders of bladder

293

1.40

1.28

1.0

30.97

44.11

ng/l

2.10

186

Enthesopathies of lower limb, excluding foot

517

1.30

1.28

1.0

33.53

42.81

ng/l

1.28

387

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

148

1211

1.19

1.27

1.0

41.15

42.85

ng/l

0.18

106

857

Leisure time condition

387

1.35

1.27

1.0

48.08

44.36

ng/l

0.19

260

Abdominal aortic aneurysm (AAA)

241

0.57

1.27

1.0

25.83

42.47

ng/l

—

146

Allergic asthma (mode), excluding more controls

438

1.32

1.26

1.0

41.41

45.39

ng/l

0.27

298

Benign neoplasm of other and unspecified endocrine glands

336

1.37

1.26

1.0

32.21

43.98

ng/l

1.80

223

Diaphragmatic hernia

127

1056

1.20

1.26

1.0

36.42

43.35

ng/l

1.19

724

Allergic conjunctivitis

153

1260

1.18

1.26

1.0

41.61

42.40

ng/l

0.08

110

892

Congenital malformations of genital organs

1.75

1.26

1.0

51.82

49.42

ng/l

0.06

Malignant neoplasm of breast, ER-negative, including Hilmo

625

0.75

1.26

1.0

47.14

48.72

ng/l

0.09

429

Ulcer of oesophagus

170

1.53

1.26

1.0

28.38

40.07

ng/l

1.27

104

Intestinal infectious diseases

291

1954

1.13

1.25

1.0

38.92

41.81

ng/l

0.66

217

1348

Polycystic ovarian syndrome, consortium definition

185

937

1.17

1.25

1.0

37.66

45.20

ng/l

1.56

125

674

Abnormalities of heart beat

111

894

1.22

1.25

1.0

39.42

46.36

ng/l

0.94

598

Keratitis

103

840

1.23

1.25

1.0

40.44

41.73

ng/l

0.12

581

Other diseases of biliary tract

216

0.55

1.24

1.0

38.43

47.01

ng/l

—

142

Endometriosis

431

1.25

1.24

1.0

43.15

44.36

ng/l

0.08

302

Chronic kidney disease

830

0.78

1.24

1.0

40.72

43.71

ng/l

0.28

537

Melanocytic naevi

677

0.75

1.24

1.0

38.97

42.88

ng/l

0.28

463

Left ventricular outflow tract obstruction (LVOTO), broad definition

253

0.59

1.23

1.0

43.39

43.19

ng/l

—

177

Vitamin deficiency, wide

1.77

1.23

1.0

21.10

48.06

ng/l

—

Vitamin deficiency

1.77

1.23

1.0

21.10

48.06

ng/l

—

Chronic diseases of tonsils and adenoids

191

1399

0.86

1.23

1.0

41.39

41.40

ng/l

0.00

142

995

Arthrosis

250

1201

1.14

1.22

1.0

39.10

41.56

ng/l

0.44

174

845

Diabetes insipidus

2.65

1.22

1.0

36.60

38.03

ng/l

—

Special screening examination for neoplasms

1.72

1.21

1.2

1.0

57.37

47.29

ng/l

—

Covid-19 suspected case

382

1.34

1.21

1.0

34.75

42.32

ng/l

0.87

266

Benign neoplasm: Colon, unspecified

764

0.77

1.20

1.0

45.91

43.50

ng/l

0.18

514

COPD differential diagnosis

268

1181

1.14

1.20

1.0

38.66

42.73

ng/l

0.94

193

820

ILD differential diagnosis

268

1181

1.14

1.20

1.0

38.66

42.73

ng/l

0.94

193

820

Heart failure, not strict

230

1782

0.88

1.20

1.0

40.50

43.11

ng/l

0.43

163

1249

Acute and subacute iridocyclitis

452

1.31

1.20

1.1

1.0

37.71

44.12

ng/l

0.97

320

COPD/asthma related infections

341

1525

1.12

1.20

1.0

37.01

42.84

ng/l

2.20

237

1072

COPD/asthma/ILD related infections

341

1525

1.12

1.20

1.0

37.01

42.84

ng/l

2.20

237

1072

Benign neoplasm: Sigmoid colon

558

1.27

1.19

1.0

34.96

42.81

ng/l

0.98

376

Disorders of lacrimal system

140

1179

1.19

1.0

39.89

44.39

ng/l

0.62

809

Liquid cancers, helper endpoint

107

1129

0.83

1.19

1.0

39.25

43.16

ng/l

0.59

762

Malignant immunoproliferative diseases

2.33

1.19

1.2

1.0

34.67

36.86

ng/l

—

Benign mammary dysplasia

323

1.36

1.19

1.0

45.06

44.79

ng/l

0.02

227

Viral conjunctivitis

2.32

1.19

1.0

31.50

38.31

ng/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.31

1.18

1.2

1.0

29.83

34.69

ng/l

—

Fracture of shoulder and upper arm

111

917

1.21

1.18

1.0

36.15

43.51

ng/l

1.28

627

Other arthrosis

197

1181

1.16

1.18

1.0

36.83

41.89

ng/l

1.16

148

833

Nephropathy related operations

323

0.65

1.18

1.0

39.90

43.47

ng/l

0.14

224

Malignant neoplasm of breast, HER-negative

558

0.74

1.18

1.0

47.66

50.66

ng/l

0.16

375

Diseases of liver

973

0.80

1.18

1.0

38.13

41.72

ng/l

0.33

670

Unspecified haematuria

145

1018

1.18

1.17

1.0

42.70

42.09

ng/l

0.07

103

677

Episcleritis

1.71

1.17

1.1

1.0

42.49

42.53

ng/l

0.00

Other symptoms and signs involving the circulatory and respiratory systems

149

1.55

1.17

1.0

64.94

43.87

ng/l

0.36

Car occupant injured in other and unspecified transport accidents

350

1.34

1.16

1.1

1.0

38.76

44.24

ng/l

0.39

238

Neuroendocrine tumor and carcinoma of small intestine

0.00

1.16

0.0

1.0

—

44.46

—

Portal vein thrombosis

0.00

1.16

0.0

1.0

—

31.02

—

Drug-induced osteoporosis

0.00

1.16

0.0

1.0

—

36.17

—

Other diseases of liver

463

0.71

1.16

1.0

37.41

43.59

ng/l

0.29

325

Primary open-angle glaucoma, strict

747

1.23

1.15

1.0

45.51

44.58

ng/l

0.08

482

Palmar fascial fibromatosis [Dupuytren]

420

1.31

1.15

1.0

40.89

44.32

ng/l

0.30

286

Frostbite

2.52

1.15

1.0

58.20

38.83

ng/l

—

Inflammatory diseases of female pelvic organs

157

985

1.17

1.14

1.0

48.52

43.11

ng/l

0.18

115

695

Other diseases of blood and blood-forming organs, wide

588

0.75

1.14

1.0

47.16

44.36

ng/l

0.20

403

Malignant neoplasm of heart, mediastinum and pleura

0.00

1.14

0.0

1.0

—

47.92

—

Brachial plexus disorders

158

1.52

1.14

1.0

31.83

41.45

ng/l

1.56

111

Other noninflammatory disorders of vagina

142

1.55

1.14

1.0

36.30

50.01

ng/l

0.90

100

Acute nasopharyngitis (common cold)

239

1.42

1.14

1.0

31.08

39.53

ng/l

0.62

173

Oxicams

301

1.28

1.14

1.0

41.91

44.64

ng/l

0.19

210

Tinnitus

616

1.25

1.13

1.0

63.93

43.49

ng/l

0.38

434

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

100

825

1.21

1.11

1.0

34.44

43.72

ng/l

2.22

571

Insulin, fast-acting

107

888

1.21

1.11

1.0

41.47

42.20

ng/l

0.06

608

Diarrhoea and gastroenteritis of presumed infectious origin

322

1905

1.11

1.0

38.49

42.05

ng/l

0.79

236

1316

Deviated nasal septum

114

952

1.20

1.11

1.1

1.0

33.34

39.85

ng/l

1.90

659

Glaucoma suspect

125

1054

1.19

1.11

1.0

40.72

42.87

ng/l

0.25

712

Examination and encounter for administrative purposes

1.79

1.11

1.0

29.67

46.72

ng/l

—

Myocardial infarction, without ST-elevation

102

1119

0.83

1.10

1.0

44.56

43.32

ng/l

0.12

743

Hypertensive heart and/or renal disease

638

0.79

1.09

1.0

39.38

46.66

ng/l

1.00

417

Disorders of conjunctiva

243

1727

1.13

1.09

1.0

41.95

42.16

ng/l

0.02

173

1209

Pulmonary heart disease, diseases of pulmonary circulation

896

0.80

1.09

1.0

36.43

43.47

ng/l

1.14

603

Status post-ami

659

0.80

1.08

1.0

43.37

43.93

ng/l

0.04

443

Other follicular disorders

128

1.57

1.08

1.0

46.08

42.39

ng/l

0.17

Pollen allergy

207

1.43

1.08

1.0

40.21

41.19

ng/l

0.05

143

Diseases of arteries, arterioles and capillaries

189

1598

0.87

1.08

1.0

38.50

42.93

ng/l

1.04

133

1070

Other maltreatment syndromes

2.19

1.08

1.0

29.57

30.96

ng/l

—

Diseases of pulp and periapical tissues, including avohilmo

333

1551

1.11

1.08

1.0

42.91

42.03

ng/l

0.12

232

1068

L02BB Anti-androgens

255

0.63

1.07

1.0

38.66

44.39

ng/l

—

156

Achilles tendinitis

244

1.40

1.07

1.0

39.53

44.17

ng/l

0.26

183

Abnormal findings on examination of blood, without diagnosis

158

1250

1.16

1.07

1.0

36.53

42.58

ng/l

1.34

111

845

Other specified and unspecified retinal disorders

1.76

1.07

1.0

60.14

38.64

ng/l

—

Cerebral aneurysm, nonruptured

219

1.42

1.06

1.0

56.56

45.99

ng/l

0.54

147

Insulin, fast-acting or short human

108

902

1.20

1.06

1.0

41.40

41.68

ng/l

0.02

618

Trochanteric bursitis

330

1.34

1.06

1.0

48.97

45.82

ng/l

0.13

223

Neuralgia and neuritis, unspecified

105

1.62

1.06

1.0

32.01

44.84

ng/l

—

Erysipelas

250

1696

1.13

1.06

1.0

34.26

43.19

ng/l

3.65

160

1197

ILD medications: immunosuppressive drugs

161

1725

0.87

1.05

1.0

40.13

40.71

ng/l

0.07

116

1230

Disorders of breast

131

1011

1.18

1.05

1.0

53.69

42.69

ng/l

0.34

714

Other congenital malformations

203

1.43

1.04

1.0

33.55

45.65

ng/l

1.22

128

Acute gastritis

170

1.47

1.04

1.0

39.60

40.93

ng/l

0.07

103

Spondylolisthesis/Spondylolysis

445

1.28

1.04

1.0

32.15

44.29

ng/l

2.56

322

Other diseases of oesophagus

220

1.41

1.04

1.0

34.80

42.58

ng/l

0.61

136

Nonspecific lymphadenitis

125

0.48

1.04

1.0

35.00

46.67

ng/l

—

Other menopausal disorders

417

0.78

1.04

1.0

42.49

44.42

ng/l

0.13

296

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

170

1436

1.15

1.04

1.1

1.0

40.15

41.80

ng/l

0.20

139

1005

Type 1 diabetes, wide definition, subgroup 1

401

1.30

1.03

1.0

40.97

42.42

ng/l

0.10

281

Benign neoplasms

301

1489

1.11

1.03

1.0

43.48

40.19

ng/l

0.63

218

1031

Insulin, fast-acting (human)

246

1.38

1.03

1.0

36.68

44.58

ng/l

0.82

163

Other protozoal intestinal diseases

2.07

1.03

1.1

1.0

31.57

34.05

ng/l

—

Noninfective enteritis and colitis

132

1126

1.17

1.02

1.0

32.39

42.04

ng/l

3.05

772

Mouth breathing

131

1117

1.17

1.02

1.0

33.84

41.09

ng/l

1.75

775

Ganglion

482

1.27

1.02

1.0

48.97

42.86

ng/l

0.43

344

Other and unspecified nerve root and plexus disorders, also in other diseases

491

1.26

1.02

1.0

42.71

41.25

ng/l

0.09

340

Acute pharyngitis

236

1.39

1.02

1.0

31.33

42.94

ng/l

1.63

164

Myalgia

518

1.26

1.01

1.0

42.36

43.30

ng/l

0.05

364

Fracture of lower leg, including ankle

176

1522

1.15

1.01

1.0

38.79

43.39

ng/l

0.80

121

1060

Fentanyl

262

0.65

1.00

1.0

42.91

49.42

ng/l

0.28

168

Panniculitis affecting regions of neck and back

1.77

1.00

1.1

1.0

32.67

47.32

ng/l

—

Excluding asthma or asthma-COPD overlap

266

1189

1.12

1.00

1.0

38.74

42.65

ng/l

0.88

191

824

Conjunctivitis

212

1565

1.13

1.00

1.0

41.19

42.50

ng/l

0.13

149

1103

Meniscus derangement

201

1191

1.14

1.00

1.0

45.31

41.70

ng/l

0.66

151

840

L02BA Anti-estrogens

380

0.71

1.00

1.1

1.0

36.75

44.09

ng/l

0.62

261

Benign neoplasm: Colon

201

1694

1.13

0.99

1.0

43.82

43.41

ng/l

0.04

136

1155

Antihypertensive medication - note that there are other indications

135

610

1.17

0.99

1.0

41.40

41.43

ng/l

0.00

469

Myocardial infarction, unclassifiable

522

0.77

0.99

1.0

45.32

44.95

ng/l

0.02

324

Other retinal disorders

218

1506

1.13

0.98

1.0

38.26

43.32

ng/l

1.03

145

1016

Alcoholic gastritis

2.18

0.98

1.2

1.0

42.20

30.66

ng/l

—

Pulmonary eosinophilia, not elsewhere classified

0.00

0.98

0.0

1.0

—

38.02

—

Acquired absence of organs, not elsewhere classified

0.00

0.98

0.0

1.0

—

36.63

—

Deforming dorsopathies

656

1.22

0.98

1.0

33.39

43.27

ng/l

2.49

481

Mesothelioma

0.00

0.97

0.0

1.0

—

48.33

—

Asthma (only as main-diagnosis), excluding more controls

224

1135

1.13

0.97

1.0

50.99

42.94

ng/l

0.38

146

792

Non-Hodgkin lymphoma, all, including Hilmo

424

0.73

0.97

1.0

43.77

44.69

ng/l

0.05

264

Universal erythroderma, KELA reimbursement

0.00

0.97

0.0

1.0

—

33.71

—

Inflammation of lacrimal passages (acute and unspecified)

0.00

0.97

0.0

1.0

—

35.42

—

Other hammer toe(s) (acquired)

486

0.76

0.97

1.1

1.0

48.73

46.50

ng/l

0.12

325

Malignant melanoma of skin

331

0.69

0.97

1.0

31.38

45.10

ng/l

1.15

210

Other sexually transmitted chlamydial diseases

1.95

0.97

1.0

30.71

29.80

ng/l

—

Enlarged lymph nodes

327

1.32

0.97

1.0

39.28

44.61

ng/l

0.56

236

Other mycoses, not elsewhere classified/unspecified

0.00

0.96

0.0

1.0

—

35.81

—

L04AA Selective immunosuppressants

537

0.76

0.96

1.0

46.98

42.98

ng/l

0.23

375

ILD, hospital admissions 1, main diag only

377

0.71

0.96

1.0

32.06

44.95

ng/l

0.77

246

Amputation

259

0.65

0.96

1.0

41.25

45.51

ng/l

0.27

156

Pleural plaque

282

0.67

0.94

1.0

36.29

43.22

ng/l

0.37

165

Soft tissue disorders related to use, overuse and pressure

750

1.20

0.94

1.0

39.53

45.28

ng/l

0.49

520

Hypothermia

1.90

0.94

1.0

32.57

34.68

ng/l

—

Postpartum hemorraghe, all women as controls

254

0.66

0.94

1.0

59.81

40.84

ng/l

0.36

195

Chronic gastritis

787

1.20

0.94

1.0

36.47

43.24

ng/l

1.25

518

Asthma mixed form (mode), excluding more controls

116

0.52

0.94

1.0

71.83

47.40

ng/l

—

Benign neoplasm: Stomach

251

1.36

0.93

1.1

1.0

44.83

46.20

ng/l

0.06

159

Viral hepatitis

117

1.54

0.93

1.1

1.0

32.64

40.72

ng/l

0.63

Ischemic heart diseases

309

1681

1.10

0.93

1.0

40.52

42.13

ng/l

0.25

206

1209

Degenerative macular diseases

312

1.32

0.93

1.0

40.71

42.69

ng/l

0.12

197

Subarachnoid haemorrhage

260

1.35

0.93

1.0

46.00

44.34

ng/l

0.06

166

Asthma (diagnoses ohter than nonallergic)

264

1973

1.11

0.92

1.0

47.23

40.95

ng/l

0.38

188

1372

Cerebral palsy and other paralytic syndromes

243

1.36

0.92

1.0

31.00

44.71

ng/l

2.41

152

Polyarthropathies

207

1200

1.13

0.92

1.0

39.21

41.55

ng/l

0.42

147

844

Peripheral artery operations in Hilmo

338

0.71

0.91

1.0

38.12

43.92

ng/l

0.59

208

Polyarthrosis

589

1.22

0.91

1.0

39.38

45.15

ng/l

0.73

395

Thyrotoxicosis with diffuse goitre

291

0.69

0.91

1.0

38.57

45.20

ng/l

0.29

205

Dermatophytosis

349

0.72

0.90

1.0

33.22

43.48

ng/l

1.16

238

Follow-up examination after treatment for malignant neoplasms

176

1.42

0.90

1.1

1.0

40.56

50.16

ng/l

0.81

124

Superficial injury of thorax

340

1.30

0.90

1.0

36.00

42.93

ng/l

0.74

230

Other condition

305

1.31

0.90

1.0

44.77

45.08

ng/l

0.02

207

Gout, FINNGEN

882

0.82

0.90

1.0

37.61

42.62

ng/l

0.66

584

Other and unspecified effects of external causes

537

1.23

0.89

1.0

44.11

42.84

ng/l

0.10

378

Injuries to the ankle and foot

154

1558

0.88

1.0

36.48

41.51

ng/l

0.85

117

1098

Other and unspecified injuries of wrist and hand

1.79

0.88

1.1

1.0

23.66

41.16

ng/l

—

DVT of lower extremities

528

0.78

0.87

1.0

42.61

43.32

ng/l

0.05

358

Maltreatment syndromes

1.86

0.87

1.1

1.0

48.75

33.64

ng/l

—

Biological medication for rheuma

323

0.71

0.87

1.0

36.32

43.12

ng/l

0.76

230

Haemorrhage from respiratory passages

116

899

1.16

0.86

1.0

43.46

44.24

ng/l

0.05

591

Use of antiglaucoma preparations and miotics

178

1.41

0.86

1.0

37.12

43.55

ng/l

0.40

110

Acute appendicitis, with complications

515

0.78

0.85

1.1

1.0

45.33

42.67

ng/l

0.16

353

Other pulmonary diagnosis

263

1189

1.11

0.85

1.0

39.04

42.65

ng/l

0.77

190

824

Asthma (only as main-diagnosis)

227

1178

1.12

0.85

1.0

50.67

42.76

ng/l

0.38

148

818

Urticaria

613

1.21

0.85

1.0

43.17

42.25

ng/l

0.07

429

Viral warts

424

0.75

0.84

1.0

41.47

43.98

ng/l

0.19

297

Nasal polyp

532

1.22

0.84

1.0

40.81

41.37

ng/l

0.04

359

Acute renal failure

614

0.80

0.84

1.0

38.56

42.93

ng/l

0.34

405

Other disorders of veins

102

1184

0.86

0.84

1.0

41.34

42.90

ng/l

0.15

835

525

0.79

0.84

1.0

45.30

45.86

ng/l

0.03

321

Polymyalgia rheumatica

355

0.73

0.84

1.0

50.12

44.69

ng/l

0.26

225

Injuries to the knee and lower leg

372

1898

1.09

0.83

1.0

37.56

42.82

ng/l

1.58

263

1316

Female infertility, cervical, vaginal, other or unspecified origin

350

0.78

0.83

1.0

34.34

45.03

ng/l

1.74

254

Diagnoses used for exclusion with ILD

660

1.20

0.83

1.0

42.76

42.75

ng/l

0.00

445

Sequelae of injuries of upper limb

222

1.35

0.83

1.1

1.0

41.45

44.81

ng/l

0.22

145

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

129

1.48

0.83

1.0

38.19

46.95

ng/l

0.69

Acetic acid derivatives and related substances

302

1.22

0.83

1.0

41.48

44.49

ng/l

0.26

211

Pulmonary heart disease

821

0.83

1.0

35.35

43.65

ng/l

1.45

555

Other disorders of bone

425

1.25

0.83

1.0

35.37

44.46

ng/l

1.38

301

Disorders of refraction and accommodation

513

1.22

0.83

1.0

45.00

42.48

ng/l

0.19

364

Myocardial infarction

151

1206

0.88

0.83

1.0

42.02

42.68

ng/l

0.08

839

Antenatal screening

168

0.70

0.82

1.0

28.37

37.08

ng/l

1.33

138

Haemorrhage, not elsewhere classified

1.70

0.82

1.1

1.0

67.20

40.58

ng/l

—

Gastroduodenal ulcer

696

1.19

0.82

1.0

40.65

44.24

ng/l

0.42

461

Collagenous colitis

214

1.36

0.82

1.0

34.05

46.61

ng/l

1.30

137

Pulmonary embolism

820

0.83

0.82

1.0

35.35

43.67

ng/l

1.45

555

Disease of hard tissues of teeth, NOS

184

854

1.13

0.82

1.0

39.40

41.43

ng/l

0.26

134

586

Injury of muscle and tendon at lower leg level

399

0.75

0.82

1.0

39.23

42.97

ng/l

0.22

278

Cellulitis

525

1.22

0.82

1.0

45.75

42.49

ng/l

0.24

360

Dental caries

566

1.21

0.81

1.0

46.32

41.05

ng/l

0.44

404

Iridocyclitis

535

1.22

0.81

1.0

38.68

42.76

ng/l

0.53

370

Polypectomy (DHB20)

172

1.40

0.81

1.0

27.27

44.43

ng/l

2.76

107

Superficial injury of wrist and hand

364

1.26

0.80

1.0

47.57

44.18

ng/l

0.11

256

Other systemic involvement of connective tissue (FG)

689

0.82

0.80

1.0

44.47

44.38

ng/l

0.01

460

Bell's palsy

285

1.30

0.80

1.0

41.06

43.94

ng/l

0.20

194

Second line medication for Crohn's disease

140

1589

0.88

0.80

1.0

39.76

42.21

ng/l

0.29

102

1103

Orchitis and epididymitis

198

1.37

0.80

1.0

39.31

42.17

ng/l

0.22

126

Leiomyosarcoma, including Hilmo

0.00

0.79

0.0

1.0

—

39.20

—

Melanoma of uvea

0.00

0.79

0.0

1.0

—

40.41

—

Carcinoid syndrome

0.00

0.79

0.0

1.0

—

36.18

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.79

0.0

1.0

—

34.64

—

Accidental poisoning by and exposure to alcohol

0.00

0.79

0.0

1.0

—

34.30

—

Varus deformity, not elsewhere classified

0.00

0.79

0.0

1.0

—

67.69

—

Failed induction of labour

0.00

0.79

0.0

1.0

—

44.22

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

692

1.19

0.79

1.0

41.10

42.38

ng/l

0.11

476

Dissociative [conversion] disorders

1.82

0.79

1.0

33.50

48.13

ng/l

—

Haemorrhage in early pregnancy

469

1.23

0.79

1.1

1.0

52.56

43.40

ng/l

0.97

339

Divergent concomitant strabismus

139

1.44

0.79

1.1

1.0

39.33

43.47

ng/l

0.20

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

838

0.83

0.79

1.0

30.16

43.09

ng/l

2.13

599

Glucagon-like peptide-1 (GLP-1) analogues

838

0.83

0.79

1.0

30.16

43.09

ng/l

2.13

599

Other and unspecified tonsillitis

450

1.21

0.79

1.1

1.0

33.14

40.86

ng/l

1.10

325

Speech therapy

683

1.19

0.79

1.0

30.94

44.28

ng/l

5.17

458

Ulcerative proctitis

106

1.51

0.78

1.0

34.36

43.66

ng/l

0.57

Other and unspecified haemorrhagic conditions

0.00

0.78

0.0

1.0

—

33.08

—

Other viral diseases

660

1.19

0.78

1.0

35.19

40.24

ng/l

0.61

470

L04AX Other immunosuppressants

137

1554

0.88

0.78

1.0

40.12

42.43

ng/l

0.26

1079

ILD medications

307

1815

0.92

0.78

1.0

38.51

41.02

ng/l

0.55

210

1279

Corneal ulcer

402

1.25

0.78

1.0

30.21

42.62

ng/l

1.92

282

Conduction disorders

819

0.85

0.77

1.0

39.38

43.90

ng/l

0.64

547

Primary open-angle glaucoma

107

894

1.16

0.77

1.0

44.38

43.97

ng/l

0.04

584

Pedal cyclist injured in transport accident

475

1.22

0.76

1.0

34.91

43.07

ng/l

1.07

332

Appendicitis, broad definition

185

1863

0.90

0.76

1.1

1.0

38.33

41.37

ng/l

0.60

138

1323

Systemic connective tissue disorders

921

0.85

0.76

1.0

43.95

43.66

ng/l

0.02

613

Myeloproliferative diseases

221

0.68

0.75

1.0

38.10

45.91

ng/l

—

141

Hydrocele

270

1.30

0.75

1.0

29.34

40.85

ng/l

2.07

172

Heterophoria

133

1.43

0.73

1.0

34.30

45.33

ng/l

—

Sub-endpoint used in defining T1D endpoints

587

1.19

0.73

1.0

39.92

40.55

ng/l

0.05

402

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

2.02

0.73

1.2

1.0

39.40

34.37

ng/l

—

Coxibs

302

1.20

0.73

1.0

39.19

44.49

ng/l

0.61

211

Diseases of appendix

188

1878

0.90

0.72

1.1

1.0

38.69

41.50

ng/l

0.55

141

1334

Opioids

302

1441

1.09

0.72

1.0

36.09

42.94

ng/l

2.73

218

996

Asthma mixed form (mode)

109

0.55

0.72

1.0

71.83

48.45

ng/l

—

Lung diseases due to external agents

326

1.26

0.71

1.0

41.14

44.02

ng/l

0.20

211

Open wound of wrist and hand

120

1030

1.14

0.71

1.0

35.72

40.94

ng/l

1.24

716

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

334

0.75

0.71

1.0

29.14

44.36

ng/l

3.38

226

Other congenital malformations of skin

134

1.42

0.71

1.0

38.92

42.66

ng/l

0.17

Caries of enamel

227

1797

0.91

0.71

1.0

36.19

41.51

ng/l

1.21

157

1283

UC patients in KELA-register (code 208), prior to 1994

109

1.47

0.71

1.1

1.0

50.50

44.30

ng/l

—

Type 1 diabetes, wide definition

425

1.22

0.71

1.0

40.97

42.93

ng/l

0.14

293

Other protozoal intestinal diseases

1.93

0.71

1.2

1.0

34.80

29.27

ng/l

—

DVT of lower extremities and pulmonary embolism

105

1197

0.87

0.70

1.0

37.94

42.79

ng/l

0.87

804

Erosion of teeth , including avohilmo

453

1.22

0.70

1.0

84.84

41.86

ng/l

0.72

317

Diseases of middle ear and mastoid

100

940

0.87

0.70

1.0

41.29

41.23

ng/l

0.01

645

Ischaemic heart disease, wide definition

296

1688

1.09

0.70

1.0

40.99

42.23

ng/l

0.17

202

1202

Endometriosis of rectovaginal septum and vagina

143

1.40

0.70

1.1

1.0

47.64

53.61

ng/l

0.22

Burns and corrosions

286

0.73

0.69

1.1

1.0

36.29

43.61

ng/l

0.50

190

Asthma, unspecified (mode)

169

1142

1.11

0.69

1.0

47.97

42.75

ng/l

0.19

123

792

Sulfonylureas

846

0.86

0.69

1.0

41.55

45.78

ng/l

0.44

556

Adhesive capsulitis of shoulder

436

1.22

0.69

1.0

47.94

43.67

ng/l

0.29

309

Lateral epicondylitis

319

1.26

0.69

1.0

42.49

42.10

ng/l

0.02

227

Other pleural conditions

262

0.72

0.68

1.1

1.0

54.59

44.34

ng/l

0.45

158

Irregular menses

106

731

1.15

0.67

1.0

33.47

44.55

ng/l

1.99

536

Spondylopathies (FG)

284

1.27

0.67

1.0

35.90

44.06

ng/l

0.98

203

Tobacco use

102

1.47

0.67

1.0

34.30

41.73

ng/l

—

Stomatitis and related lesions

430

0.79

0.67

1.0

45.17

42.85

ng/l

0.13

294

Other diseases of the digestive system

863

1.15

0.67

1.0

36.79

43.58

ng/l

0.95

575

Carpal tunnel syndrome

196

1568

1.10

0.67

1.0

41.52

42.09

ng/l

0.07

142

1095

Gonarthrosis [arthrosis of knee](FG)

281

1504

1.09

0.67

1.0

38.79

43.09

ng/l

0.98

194

1068

Seropositive rheumatoid arthritis, strict definition

385

0.78

0.67

1.0

44.90

45.08

ng/l

0.01

259

Atopic dermatitis, strict definition

411

1.22

0.66

1.1

1.0

30.83

43.36

ng/l

3.01

286

Exposure to other specified factors

220

1844

1.10

0.66

1.0

42.97

41.00

ng/l

0.23

167

1287

Ankylosing spondylitis

179

1.34

0.66

1.0

37.49

44.80

ng/l

0.61

131

Nummular dermatitis

214

1.31

0.66

1.0

34.67

45.39

ng/l

1.05

142

Hernia of abdominal wall

116

1312

0.88

0.66

1.0

41.61

41.94

ng/l

0.02

897

Fitting and adjustment of other devices

121

966

1.13

0.66

1.0

48.87

44.76

ng/l

0.48

616

ILD, hospital admission 2, with pulmonary infections

260

0.73

0.66

1.0

27.80

47.22

ng/l

—

173

Other and unspecified vascular occlusions

232

1.30

0.66

1.0

33.50

42.42

ng/l

0.78

142

Secondary uncertain malignant neoplasm

395

0.78

0.65

1.0

40.57

45.53

ng/l

0.35

249

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

206

1.31

0.65

1.0

29.20

47.15

ng/l

2.00

130

Other symptoms and signs involving the urinary system

259

1.28

0.65

1.0

31.22

43.94

ng/l

2.08

169

Disorder of lipoprotein metabolism, unspecified

385

1.22

0.65

1.0

46.00

46.81

ng/l

0.04

249

Viral warts

190

0.68

0.65

1.0

46.71

44.07

ng/l

—

124

Cholelithiasis

242

1815

0.92

0.64

1.0

50.85

40.99

ng/l

0.55

155

1272

Separation of retinal layers (serosa)

1.48

0.64

1.1

1.0

32.29

38.60

ng/l

—

Female infertility

354

0.82

0.64

1.0

34.37

45.09

ng/l

1.78

256

Codeine

287

1440

1.08

0.64

1.0

35.32

42.97

ng/l

3.23

201

995

Asthma, unspecified (mode), excluding more controls

164

1106

1.11

0.64

1.0

47.91

43.04

ng/l

0.17

121

771

Familial hypercholesterolemia

450

1.20

0.63

1.0

39.63

47.40

ng/l

0.66

289

Tumor necrosis factor alpha inhibitors

281

0.75

0.63

1.0

36.36

43.50

ng/l

0.72

198

Diseases of external ear

100

877

1.14

0.63

1.0

34.84

42.54

ng/l

1.65

603

Adjustment and management of implanted device

492

0.81

0.63

1.0

40.54

45.52

ng/l

0.58

307

Paralytic ileus and intestinal obstruction

690

1.16

0.63

1.0

37.56

44.86

ng/l

1.22

463

Chronic ulcer of skin, not elsewhere classified

165

0.67

0.63

1.1

1.0

38.67

42.96

ng/l

—

104

Deep endometriosis

155

1.36

0.63

1.0

47.64

47.21

ng/l

0.01

103

Other specified and unspecified personality disorders

155

1.36

0.63

1.0

32.27

42.69

ng/l

1.08

Early onset COPD, excluding more controls

600

0.83

0.62

1.0

43.54

44.61

ng/l

0.06

411

Other and unspecified urticaria

396

1.21

0.62

1.0

39.00

45.02

ng/l

0.60

269

Mycoses

256

2054

1.08

0.62

1.0

36.23

42.37

ng/l

2.14

179

1438

Wet age-related macular degeneration

423

0.80

0.62

1.1

1.0

38.65

46.18

ng/l

0.59

257

Allergic contact dermatitis

270

1.26

0.62

1.0

50.77

47.39

ng/l

0.16

181

Ventral hernia

643

0.84

0.62

1.1

1.0

41.20

44.17

ng/l

0.20

447

Nonsuppurative otitis media

281

0.77

0.61

1.0

41.76

45.72

ng/l

0.23

181

Other sexually transmitted chlamydial diseases

1.67

0.61

1.0

20.20

31.28

ng/l

—

Inflammatory bowel disease

702

1.15

0.61

1.0

32.90

42.41

ng/l

1.82

500

Other/unspecified enthesopathies of lower limb, excluding foot

130

1.39

0.61

1.0

20.18

47.24

ng/l

5.10

Prepatellar bursitis

113

1.42

0.61

1.0

24.91

48.54

ng/l

2.52

Scleritis and episcleritis

113

1.42

0.61

1.1

1.0

42.49

43.05

ng/l

0.02

Other systemic involvement of connective tissue

685

0.85

0.61

1.0

44.03

44.32

ng/l

0.02

463

Erysipelas

187

1508

1.10

0.61

1.0

35.73

42.06

ng/l

1.94

117

1050

Asthma, hospital admissions , main diagnosis only

237

1926

1.09

0.60

1.0

50.23

40.72

ng/l

0.51

155

1350

Other congenital malformations of upper alimentary tract

0.00

0.60

0.0

1.0

—

34.03

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

0.60

0.0

1.0

—

43.74

—

Corticotropin deficiency

0.00

0.60

0.0

1.0

—

36.90

—

Diabetic retinopathy

535

1.14

0.60

1.0

31.03

38.38

ng/l

1.80

368

Glaucoma secondary to eye inflammation

0.00

0.60

0.0

1.0

—

38.09

—

Other viral diseases, not elsewhere classified

441

1.20

0.60

1.0

35.71

42.77

ng/l

0.75

305

Primary adrenocortical insufficiency

0.00

0.60

0.0

1.0

—

35.20

—

Certolizumab pegol

0.00

0.60

0.0

1.0

—

44.15

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.60

0.0

1.0

—

37.25

—

Acute drug-induced interstitial lung disorder

0.00

0.60

0.0

1.0

—

36.02

—

Aspergillosis

0.00

0.60

0.0

1.0

—

34.28

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

0.00

0.60

0.0

1.0

—

37.02

—

Herpesviral [herpes simplex] infections

244

0.74

0.60

1.0

31.90

45.75

ng/l

—

164

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

355

0.79

0.60

1.0

28.59

47.71

ng/l

4.01

212

Gonarthrosis

228

1193

1.09

0.59

1.0

39.39

41.69

ng/l

0.40

152

839

Cardiomyopathies, Secondary/extrinsic

0.00

0.59

0.0

1.0

—

35.91

—

Osteitis due to dental implant

0.00

0.59

0.0

1.0

—

35.83

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

0.00

0.59

0.0

1.0

—

40.95

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

309

1985

1.07

0.59

1.0

41.39

41.57

ng/l

0.03

229

1376

Combined immunodeficiencies

0.00

0.58

0.0

1.0

—

33.11

—

Dissocial personality disorder

0.00

0.58

0.0

1.0

—

28.88

—

Benign neoplasm of eye and adnexa

265

0.75

0.58

1.0

49.29

44.53

ng/l

0.18

165

Urticaria and erythema

790

1.14

0.58

1.0

40.62

42.71

ng/l

0.22

553

Visual impairment including blindness (binocular or monocular)

123

1.38

0.57

1.0

53.83

45.70

ng/l

0.23

Other diseases of upper respiratory tract

353

1721

1.07

0.57

1.0

41.18

42.24

ng/l

0.16

249

1188

Other necrotizing vasculopathies (FG)

149

1.35

0.57

1.0

42.85

48.42

ng/l

0.25

Corns and callosities

149

1.34

0.57

1.1

1.0

43.00

41.80

ng/l

—

Atypical facial pain

106

1.42

0.57

1.0

48.06

44.17

ng/l

—

Hydronephrosis

287

0.77

0.57

1.0

49.31

44.47

ng/l

0.28

186

Cholelithiasis, broad definition with cholecystitis

254

1844

0.93

0.57

1.0

50.43

41.33

ng/l

0.51

160

1294

GI-bleeding

857

1.13

0.57

1.0

33.47

43.70

ng/l

2.38

571

Seropositive rheumatoid arthritis

741

0.86

0.57

1.0

41.93

46.49

ng/l

0.37

494

Raynaud syndrome

167

1.32

0.56

1.0

34.64

44.61

ng/l

0.70

100

Complications of medical and surgical care

230

1954

1.08

0.56

1.0

36.42

42.92

ng/l

2.15

163

1352

Polyp of the female genital tract

429

0.86

0.56

1.0

33.35

44.34

ng/l

2.28

301

Gastric ulcer

466

1.18

0.56

1.0

38.18

44.65

ng/l

0.69

294

Chronic lower respiratory diseases

373

1864

1.07

0.56

1.0

43.06

41.22

ng/l

0.13

265

1303

Ankylosing spondylitis, ICD10

185

1.30

0.56

1.0

37.49

41.53

ng/l

0.28

120

Corneal degeneration

1.63

0.55

1.0

48.17

37.20

ng/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.63

0.55

1.0

39.50

33.06

ng/l

—

Diabetic nephropathy, excluding more controls

255

1.23

0.55

1.0

44.79

39.89

ng/l

0.36

174

Malignant neoplasm of bladder

183

0.71

0.55

1.0

44.71

46.63

ng/l

—

107

Streptococcal septicaemia

206

0.73

0.55

1.0

34.40

46.94

ng/l

—

130

Open wound of forearm

183

0.71

0.55

1.0

37.57

42.13

ng/l

—

115

Diseases of the digestive system

136

1223

1.11

0.55

1.0

35.90

43.22

ng/l

1.35

817

Coxarthrosis

187

1131

1.09

0.55

1.0

37.28

42.28

ng/l

1.05

121

791

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

122

690

1.12

0.55

1.0

37.06

44.04

ng/l

1.44

515

Dermatitis and eczema

340

1976

1.07

0.54

1.0

43.15

41.40

ng/l

0.11

242

1378

Acne vulgaris

1.58

0.54

1.2

1.0

22.67

29.68

ng/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

239

0.75

0.54

1.1

1.0

28.42

43.97

ng/l

1.44

159

Infections of the skin and subcutaneous tissue

160

1446

1.10

0.54

1.0

38.41

40.57

ng/l

0.30

112

1008

Primary_lymphoid and hematopoietic malignant neoplasms

697

0.86

0.54

1.1

1.0

41.42

43.67

ng/l

0.18

464

Noninfectious colitis NAS

285

1.23

0.53

1.0

25.83

44.74

ng/l

6.25

187

Injuries to unspecified part of trunk, limb or body region

216

0.74

0.53

1.0

47.94

44.39

ng/l

—

137

Misadventures to patients during surgical and medical care

349

1.20

0.53

1.0

33.10

43.52

ng/l

1.60

235

Other noninflammatory disorders of uterus, except cervix

405

0.85

0.53

1.0

49.34

45.24

ng/l

0.38

282

Other infective otitis externa

134

1.35

0.53

1.0

39.39

45.22

ng/l

0.35

Demyelinating diseases of the central nervous system

134

1.34

0.53

1.2

1.0

25.71

44.05

ng/l

2.69

Postprocedural musculoskeletal disorders, not elsewhere classified

187

1.29

0.52

1.1

1.0

26.47

44.23

ng/l

2.67

114

Dentofacial anomalies [including malocclusion]

155

1363

0.91

0.52

1.0

37.90

42.52

ng/l

0.88

107

979

Secondary hypertension

176

1.29

0.52

1.1

1.0

38.21

46.23

ng/l

0.43

122

Obstructed labour due to maternal pelvic abnormality

350

1.20

0.52

1.0

41.83

42.28

ng/l

0.02

253

ILD, hospital admissions 3, with pneumonia sepsis

215

0.74

0.52

1.0

30.00

44.93

ng/l

—

135

Other/unspecified seropositive rheumatoid arthritis

727

0.87

0.52

1.0

42.08

44.03

ng/l

0.15

488

Overexertion and strenuous or repetitive movements

223

1.26

0.52

1.0

29.05

44.97

ng/l

2.24

144

Gestational diabetes (for exclusion)

251

0.80

0.52

1.0

30.20

41.87

ng/l

1.62

193

Polyarthritis, unspecified

1.45

0.52

1.0

32.47

46.69

ng/l

—

Other abnormal findings of blood chemistry

100

1.40

0.52

1.0

23.63

46.94

ng/l

—

Mycoses

672

0.86

0.51

1.0

38.69

43.42

ng/l

0.57

457

Varicose veins

186

1523

0.92

0.51

1.0

43.76

43.10

ng/l

0.08

123

1059

Dermatitis due to substances taken internally

109

1.38

0.51

1.1

1.0

25.60

47.25

ng/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

191

1849

0.92

0.50

1.0

35.46

43.49

ng/l

2.24

147

1256

Haemorrhoids and perianal venous thrombosis

101

902

1.12

0.50

1.0

60.59

43.73

ng/l

0.37

608

Procreative management

525

1.14

0.50

1.0

37.33

40.65

ng/l

0.25

373

Venous thromboembolism

148

1562

0.91

0.50

1.0

39.10

43.43

ng/l

0.72

1060

Personal history of other diseases and conditions

135

1.33

0.49

1.0

40.07

43.13

ng/l

0.13

Gout

730

0.88

0.49

1.0

37.61

43.14

ng/l

0.74

500

Biomechanical lesions, not elsewhere classified

110

1.37

0.48

1.0

27.67

45.65

ng/l

—

Benign neoplasm: Rectum

539

1.15

0.48

1.0

43.53

44.45

ng/l

0.07

358

Preterm labour and delivery

539

1.15

0.48

1.0

36.00

41.10

ng/l

0.52

395

Diseases of the skin and subcutaneous tissue

319

1504

1.06

0.48

1.0

39.31

41.67

ng/l

0.50

213

1050

Non-allergic asthma (mode)

488

1.16

0.48

1.0

44.46

45.65

ng/l

0.07

323

Other inflammation of eyelid

308

1.20

0.48

1.0

35.20

45.06

ng/l

1.25

205

Melanocytic naevi of trunk

256

0.78

0.47

1.0

34.53

44.60

ng/l

0.90

163

Dislocation, sprain and strain of joints and ligaments at neck level

254

1.22

0.46

1.0

34.86

44.15

ng/l

0.72

171

Recurrent aphthous stomatitis , including avohilmo

310

0.81

0.46

1.0

45.46

45.17

ng/l

0.01

198

Other diseases of lip and oral mucosa

120

1091

1.10

0.46

1.0

39.72

43.96

ng/l

0.64

755

Chronic periodontitis, complicated

188

1728

1.08

0.46

1.0

39.83

42.33

ng/l

0.40

136

1220

Conjunctivitis (acute, non atopic)

577

1.14

0.46

1.0

39.44

42.38

ng/l

0.12

398

Hypoparathyroidism

1.43

0.45

1.0

25.00

48.77

ng/l

—

Seropositive rheumatoid arthritis, wide

728

0.88

0.45

1.0

41.93

44.04

ng/l

0.17

489

Idiopathic gout

265

0.79

0.45

1.0

37.54

44.16

ng/l

0.55

169

Other viral diseases

513

1.15

0.45

1.0

36.83

40.79

ng/l

0.35

367

Other joint disorders

245

1208

1.07

0.45

1.0

40.46

41.46

ng/l

0.14

174

850

Other diseases of anus and rectum

796

1.12

0.45

1.0

38.22

44.34

ng/l

0.89

539

Otalgia

147

1.29

0.45

1.0

48.27

43.14

ng/l

0.23

Other medical care

122

1202

0.91

0.45

1.0

39.82

45.30

ng/l

0.72

792

Presence of other devices

663

1.13

0.45

1.1

1.0

44.96

45.77

ng/l

0.07

419

Female genital prolapse

428

1.12

0.44

1.0

36.60

44.34

ng/l

1.12

301

Benign neoplasm: Transverse colon

311

1.19

0.44

1.0

61.41

45.44

ng/l

0.46

207

Other septicaemia

114

997

1.10

0.44

1.0

38.00

43.96

ng/l

1.21

670

Hypertrophy of breast in women and men

413

1.16

0.44

1.0

38.93

41.09

ng/l

0.13

281

Decubitus ulcer and pressure area

130

1.31

0.44

1.1

1.0

52.85

42.42

ng/l

—

Cholecystectomy

197

1822

0.93

0.43

1.0

54.50

40.96

ng/l

0.63

125

1268

Problems related to lifestyle

202

1.24

0.43

1.0

40.50

46.61

ng/l

0.52

133

Bronchitis

295

1966

0.94

0.42

1.0

36.28

42.71

ng/l

2.19

202

1370

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

713

0.88

0.42

1.0

42.08

44.12

ng/l

0.16

482

Other symptoms and signs involving the digestive system and abdomen

396

1.16

0.42

1.0

40.31

43.28

ng/l

0.27

263

Other bacterial intestinal infections

546

1.14

0.42

1.0

34.98

44.09

ng/l

1.83

367

All influenza (not pneumonia)

331

1.18

0.42

1.1

1.0

31.23

42.58

ng/l

2.19

227

Diseases of arteries, arterioles and capillaries (FINNGEN)

531

0.89

0.42

1.0

41.78

46.46

ng/l

0.50

395

Melanoma in situ of other and unspecified parts of face

1.57

0.42

1.0

33.80

31.27

ng/l

—

Sarcoidosis

322

1.18

0.42

1.0

44.13

44.65

ng/l

0.03

217

Acute bronchitis

946

0.90

0.42

1.0

35.93

43.11

ng/l

1.32

629

AV-block

513

0.87

0.42

1.0

38.42

44.06

ng/l

0.57

323

Disorders of tooth development and eruption

212

0.80

0.41

1.0

24.10

40.67

ng/l

—

155

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.0

—

36.86

—

Dermatopolymyositis, unspecified

0.00

0.41

0.0

1.0

—

39.78

—

Aplastic and other anaemias

122

1239

0.92

0.41

1.0

41.34

43.54

ng/l

0.28

803

Heartburn

249

1.21

0.41

1.1

1.0

31.95

42.94

ng/l

1.62

170

Toxoplasmosis

0.00

0.41

0.0

1.0

—

37.25

—

Idiopathic hypercalciuria

0.00

0.41

0.0

1.0

—

45.43

—

Deformity of finger(s)

0.00

0.41

0.0

1.0

—

34.44

—

Lower leg

0.00

0.41

0.0

1.0

—

35.89

—

Anuria and oliguria

0.00

0.41

0.0

1.0

—

34.54

—

Increased muscle tone

0.00

0.41

0.0

1.0

—

32.75

—

Panhypopituitarism

1.52

0.41

1.0

60.80

35.94

ng/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.41

0.0

1.0

—

33.81

—

Other specified/unspecified nutritional deficiencies

0.00

0.41

0.0

1.0

—

35.00

—

Melanocytic naevi of lip

0.00

0.41

0.0

1.0

—

34.67

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.41

0.0

1.0

—

34.67

—

Recurrent and persistent haematuria

0.00

0.41

0.0

1.0

—

35.81

—

ILD medications: nintedanib

0.00

0.41

0.0

1.0

—

39.96

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.41

0.0

1.0

—

44.62

—

Melanoma in situ of lower limb, including hip

0.00

0.41

0.0

1.0

—

44.82

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.41

0.0

1.0

—

38.60

—

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.0

—

36.86

—

Other and unspecified disorders of pigmentation

0.00

0.41

0.0

1.0

—

33.81

—

Valgus deformity, not elsewhere classified

0.00

0.41

0.0

1.0

—

38.75

—

Other injuries of spine and trunk, level unspecified

0.00

0.41

0.0

1.0

—

34.29

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.41

0.0

1.0

—

27.00

—

Nonalcoholic fatty liver disease

228

0.79

0.41

1.0

30.83

45.19

ng/l

0.70

155

Other (seronegative) rheumatoid arthritis, wide

477

0.86

0.41

1.0

42.07

44.36

ng/l

0.13

326

Paget disease

0.00

0.41

0.0

1.0

—

36.90

—

Infarction of spleen

0.00

0.41

0.0

1.0

—

34.88

—

Atlantoaxial subluxation

0.00

0.41

0.0

1.0

—

43.75

—

Other and unspecified acne

0.00

0.40

0.0

1.0

—

35.90

—

Use of glatiramer acetate

0.00

0.40

0.0

1.0

—

33.91

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.40

0.0

1.0

—

33.25

—

Coxarthrosis [arthrosis of hip](FG)

207

1363

1.07

0.40

1.0

38.48

44.05

ng/l

1.14

136

961

Polycystic ovarian syndrome

0.00

0.40

0.0

1.0

—

43.10

—

Complications of procedures, not elsewhere classified

250

1949

1.06

0.40

1.0

41.22

42.10

ng/l

0.14

174

1367

Peritonsillar abscess

423

0.85

0.40

1.0

37.32

40.35

ng/l

0.22

299

Pregnancy hypertension

721

0.89

0.40

1.1

1.0

42.69

43.80

ng/l

0.08

530

Inflammatory bowel disease, strict (require KELA)

464

1.14

0.40

1.0

36.71

42.02

ng/l

0.51

332

Fibrosis of liver

0.00

0.40

0.0

1.0

—

44.79

—

Cervical root disorders

0.00

0.40

0.0

1.0

—

39.00

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

35.67

—

Lung transplant status

0.00

0.40

0.0

1.0

—

36.45

—

Lung transplantation

0.00

0.40

0.0

1.0

—

36.45

—

Malignant neoplasm of parotid gland

0.00

0.40

0.0

1.0

—

35.03

—

Blindness, monocular

0.00

0.40

0.0

1.0

—

37.93

—

Acute mastoiditis

0.00

0.40

0.0

1.0

—

43.50

—

Other injuries of lower limb, level unspecified

0.00

0.40

0.0

1.0

—

37.25

—

Other and unspecified acquired haemolytic anaemias

0.00

0.40

0.0

1.0

—

34.03

—

Benign neoplasm: Short bones of lower limb

0.00

0.40

0.0

1.0

—

41.30

—

Striae atrophicae

0.00

0.40

0.0

1.0

—

43.50

—

Migraine without aura, drug-induced

0.00

0.40

0.0

1.0

—

32.64

—

Other contact dermatitis

159

1.26

0.40

1.1

1.0

37.85

46.82

ng/l

0.44

101

Use of cabergoline

0.00

0.40

0.0

1.0

—

38.04

—

Assault by sharp object

0.00

0.40

0.0

1.0

—

29.45

—

Non-allergic asthma (mode), excluding more controls

497

1.14

0.40

1.0

44.46

46.74

ng/l

0.15

325

Abnormal serum enzyme levels

103

915

1.10

0.40

1.0

39.81

42.07

ng/l

0.24

614

Congenital malformations of great arteries

0.00

0.39

0.0

1.0

—

40.75

—

Injury of muscle and tendon at wrist and hand level

315

1.18

0.39

1.0

34.41

42.16

ng/l

0.92

225

Toxic effects of substances chiefly nonmedicinal as to source

232

1.21

0.39

1.0

40.14

45.97

ng/l

0.42

152

Preparatory care for dialysis

102

0.68

0.39

1.0

63.71

44.53

ng/l

—

Anomalies of dental arch relationship, including avohilmo

293

0.83

0.39

1.0

32.67

43.61

ng/l

0.90

200

Purpura and other haemorrhagic conditions

303

0.82

0.39

1.0

39.45

42.91

ng/l

0.23

196

Complications peculiar to reattachment and amputation

0.00

0.39

0.0

1.0

—

36.75

—

Leiomyosarcoma

0.00

0.39

0.0

1.0

—

43.25

—

Polyarteritis nodosa

0.00

0.39

0.0

1.0

—

39.43

—

Malignant neoplasm of eye and adnexa

0.00

0.39

0.0

1.0

—

41.95

—

Use of entacapone

0.00

0.39

0.0

1.0

—

36.53

—

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.0

—

39.63

—

Nail disorders

160

1.25

0.38

1.1

1.0

29.39

42.12

ng/l

0.89

103

Lichen planus, including avohilmo

504

1.13

0.38

1.0

36.40

44.63

ng/l

0.99

347

Atopic dermatitis, strict definition with reimbursement

450

1.14

0.38

1.1

1.0

30.95

42.13

ng/l

2.69

321

Temporomandibular joint disorders, including avohilmo

853

1.10

0.38

1.0

36.98

42.12

ng/l

0.87

621

Impacted cerumen

252

1.19

0.37

1.0

28.35

44.29

ng/l

2.25

164

IBD patients in KELA-register

467

1.14

0.37

1.0

36.71

43.20

ng/l

0.66

331

Hypercalcemia

1.33

0.37

1.0

28.13

47.71

ng/l

—

Traumatic amputation of wrist and hand

107

1.31

0.37

1.0

46.75

41.69

ng/l

—

Rheumatoid arthritis, including avohilmo

1071

0.91

0.37

1.0

39.29

45.16

ng/l

0.76

725

Chronic rhinitis, nasopharyngitis and pharyngitis

800

1.10

0.37

1.0

41.85

43.59

ng/l

0.13

555

Triptan medication for migraine, min. 3 purchases

109

905

0.92

0.37

1.0

36.71

42.33

ng/l

0.76

667

Benign neoplasm: Adrenal gland

216

1.21

0.36

1.0

35.50

46.27

ng/l

0.88

135

Uterine polyps

224

0.80

0.36

1.0

29.74

46.38

ng/l

1.84

161

Major coronary heart disease event excluding revascularizations

202

1430

0.94

0.36

1.0

39.27

43.36

ng/l

0.73

132

1005

Benign lipomatous neoplasm

802

1.10

0.36

1.0

36.14

42.63

ng/l

1.17

551

Delivery, wide proxy

338

1.12

0.36

1.0

47.30

45.04

ng/l

0.13

214

Pregnancy, childbirth and the puerperium

278

1.13

0.35

1.0

47.29

43.97

ng/l

0.17

176

Crohn disease

263

1.18

0.35

1.0

35.36

45.60

ng/l

0.73

179

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.63

0.35

1.0

60.80

55.11

ng/l

—

Pleural plaque with presence of asbestos

201

0.79

0.35

1.0

32.09

43.35

ng/l

0.59

123

Presence of cardiac and vascular implants and grafts

137

1095

0.93

0.35

1.0

38.18

42.35

ng/l

0.80

725

All dysplastic lesions of the cervix uteri

307

0.84

0.35

1.0

32.44

41.16

ng/l

1.01

227

ILD medications: prednisolone, methylprednisolone, prednisone

309

1814

0.95

0.35

1.0

38.73

41.04

ng/l

0.51

212

1278

Atopic dermatitis

137

1043

1.08

0.35

1.0

50.12

40.98

ng/l

0.31

106

739

Fenamates

222

1.16

0.35

1.0

48.54

44.53

ng/l

0.21

152

Infections with a predominantly sexual mode of transmission

469

1.13

0.35

1.0

35.28

42.25

ng/l

0.89

327

Pilonidal cyst

117

1.28

0.35

1.0

23.67

36.33

ng/l

—

Acute appendicitis

179

1780

0.94

0.35

1.1

1.0

38.55

41.14

ng/l

0.47

133

1268

Single spontaneous delivery

459

1.10

0.35

1.0

44.53

43.79

ng/l

0.05

310

Other disorders of bone density and structure

1.40

0.35

1.2

1.0

31.67

33.21

ng/l

—

Other disorders of breast

245

1.18

0.35

1.1

1.0

102.05

45.60

ng/l

0.40

175

Retinal vascular occlusion

301

1.16

0.35

1.0

32.72

42.79

ng/l

1.15

186

Congenital malformations of heart and great arteries

226

0.81

0.34

1.0

31.43

44.22

ng/l

1.73

149

Other acute lower respiratory infections

117

1204

0.93

0.34

1.0

35.38

42.23

ng/l

1.46

819

Diabetic maculopathy, excluding more controls

236

1.19

0.34

1.0

26.24

43.60

ng/l

2.89

158

Glucosamine medication

169

1264

1.07

0.34

1.0

54.70

43.42

ng/l

0.42

110

863

Ectopic pregnancy

373

0.86

0.34

1.0

38.35

41.21

ng/l

0.23

274

Asthma-related pneumonia

908

1.09

0.34

1.0

58.35

43.29

ng/l

0.30

599

Superficial injury of ankle and foot

200

0.80

0.34

1.1

1.0

31.00

45.57

ng/l

—

130

Pain and other conditions associated with female genital organs and menstrual cycle

294

1.16

0.34

1.1

1.0

36.18

45.66

ng/l

1.02

214

Combinations of oral blood glucose lowering drugs

891

1.09

0.34

1.1

1.0

33.53

43.35

ng/l

2.22

620

Ulcerative rectosigmoiditis

172

1.22

0.34

1.0

37.56

44.34

ng/l

0.52

113

Other disorders of prostate

1.34

0.34

1.0

27.17

42.85

ng/l

—

Injury of eye and orbit

283

1.17

0.34

1.0

41.13

44.56

ng/l

0.23

194

Other arrhythmias

193

1544

0.94

0.34

1.0

40.80

42.87

ng/l

0.30

130

1098

Varicose veins of other sites

154

1.24

0.34

1.0

30.33

43.61

ng/l

1.44

103

Allergic purpura

1.33

0.33

1.0

31.00

35.00

ng/l

—

Other and unspecified injuries of lower leg

136

1.25

0.33

1.1

1.0

36.95

42.82

ng/l

0.24

Endometriosis ASRM stages 3,4

415

1.13

0.33

1.0

46.85

44.16

ng/l

0.15

288

Other disorders of optic [2nd] nerve and visual pathways

127

1.26

0.33

1.0

45.77

45.43

ng/l

0.01

Delivery

459

1.09

0.33

1.0

43.87

43.79

ng/l

0.01

310

Noninflammatory disorders of female genital tract

431

0.91

0.33

1.0

43.13

44.36

ng/l

0.10

302

Asthma/COPD (KELA code 203)

285

1863

1.05

0.32

1.0

47.26

41.22

ng/l

0.38

194

1303

Effects of foreign body entering through natural orifice

568

1.11

0.32

1.0

37.80

41.15

ng/l

0.38

401

Ovarian cyst

431

1.10

0.32

1.0

45.21

44.36

ng/l

0.06

302

Diseases of the respiratory system

207

980

1.06

0.32

1.0

43.70

43.64

ng/l

0.01

138

680

Spondyloarthritis

379

1.13

0.32

1.0

33.33

44.26

ng/l

1.86

269

Asthma-related pneumonia or sepsis

913

1.08

0.31

1.0

58.35

43.37

ng/l

0.30

603

Asthma, hospital admissions 3, pneumonia

913

1.08

0.31

1.0

58.35

43.37

ng/l

0.30

603

Seronegative rheumatoid arthritis

305

0.85

0.31

1.0

46.67

45.87

ng/l

0.03

213

Benign neoplasm of major salivary glands

262

0.84

0.31

1.0

47.14

45.47

ng/l

0.05

171

Other diseases of intestine

399

1.13

0.31

1.0

37.75

44.67

ng/l

0.97

270

Lichen ruber planus, wide definition including periferal and oral lichen planus

599

1.10

0.31

1.0

37.90

43.56

ng/l

0.65

419

Complications predominantly related to the puerperium

437

1.12

0.31

1.0

73.03

42.64

ng/l

0.40

314

Benign neoplasm: Tongue

1.32

0.31

1.1

1.0

14.71

48.23

ng/l

—

Vitamin B12 deficiency anaemia

258

1.16

0.30

1.1

1.0

29.45

44.48

ng/l

1.63

158

Retinal vascular disorders

305

1.15

0.30

1.0

32.72

42.98

ng/l

1.19

188

Other disorders of skin and subcutaneous tissue, not elsewhere classified

347

0.86

0.30

1.1

1.0

33.67

44.76

ng/l

1.24

235

Herpesviral [herpes simplex] infections

495

0.89

0.30

1.0

35.37

43.21

ng/l

0.94

344

Chalazion

249

1.17

0.30

1.1

1.0

42.80

45.04

ng/l

0.10

168

Other peripheral vascular diseases

184

1.20

0.30

1.0

42.43

45.14

ng/l

0.13

109

Other female pelvic inflammatory diseases

343

1.14

0.30

1.0

39.87

45.64

ng/l

0.41

235

Obstructed labour due to malposition and malpresentation of fetus

267

1.15

0.30

1.0

39.26

38.46

ng/l

0.03

210

Other and unspecified visual disturbances

240

1.17

0.30

1.0

28.57

44.01

ng/l

2.08

155

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

312

1914

1.04

0.30

1.0

41.29

41.88

ng/l

0.09

210

1350

Short Achilles tendon (acquired)

1.27

0.30

1.3

1.0

30.00

46.47

ng/l

—

Care involving dialysis

185

0.81

0.29

1.0

53.76

40.76

ng/l

—

121

Asthma-related infections

157

1449

1.06

0.29

1.0

53.16

41.77

ng/l

0.37

985

Asthma, hospital admission 2, infections

157

1449

1.06

0.29

1.0

53.16

41.77

ng/l

0.37

985

Other heart diseases, wide

282

1649

1.05

0.29

1.0

40.42

41.83

ng/l

0.22

196

1179

Other disorders of skin and subcutaneous tissue

217

1834

1.05

0.29

1.0

40.43

43.01

ng/l

0.41

141

1270

Dermatophytosis

176

1664

1.06

0.29

1.0

35.28

42.15

ng/l

1.98

121

1164

Complications of labour and delivery

141

835

0.94

0.29

1.0

55.06

41.80

ng/l

0.47

101

604

Azathioprine

316

1.14

0.29

1.0

40.27

44.21

ng/l

0.23

225

Injuries involving multiple body regions

1.23

0.29

1.1

1.0

43.71

41.66

ng/l

—

Arthropathies

250

1208

1.05

0.29

1.0

39.24

41.46

ng/l

0.39

179

850

Other and unspecified dermatitis

150

1414

1.06

0.28

1.0

34.14

41.66

ng/l

2.26

976

Phlebitis and thrombophlebitis (not including DVT)

597

0.90

0.28

1.0

35.74

42.82

ng/l

0.85

417

Trigger finger

364

1.13

0.28

1.0

36.88

43.66

ng/l

0.58

253

Excessive attrition of teeth

150

1415

1.06

0.28

1.0

38.57

42.14

ng/l

0.59

110

1003

Squamous cell neoplasms and carcinomas of the skin

216

0.83

0.28

1.0

28.79

49.55

ng/l

—

126

Otitis externa

507

1.11

0.28

1.0

37.26

43.80

ng/l

0.83

354

Spirochaetal infections, other/unspecified

223

1.17

0.28

1.1

1.0

41.48

46.28

ng/l

0.27

146

Acute upper respiratory infections of multiple and unspecified sites

188

1467

0.95

0.28

1.0

35.26

43.11

ng/l

2.12

135

1022

Cholangitis (primary sclerosing, PSC)

129

0.77

0.28

1.0

70.60

46.18

ng/l

—

Disturbances of skin sensation

603

1.09

0.28

1.0

62.10

42.40

ng/l

0.31

425

Lesion of ulnar nerve

355

1.13

0.28

1.0

43.38

41.02

ng/l

0.07

252

Benign neoplasm: Ascending colon

393

1.12

0.28

1.0

54.79

44.27

ng/l

0.31

266

Thyroiditis, ILD-related definition

214

1.17

0.27

1.0

46.98

44.91

ng/l

0.08

151

Other hearing loss

695

0.91

0.27

1.0

41.69

45.71

ng/l

0.40

452

Other skin changes

491

0.90

0.27

1.0

39.60

44.57

ng/l

0.51

330

Obesity and other hyperalimentation

157

1598

0.95

0.27

1.0

31.94

42.17

ng/l

4.24

114

1128

Conductive hearing loss, unspecified

177

1.19

0.27

1.0

30.92

41.18

ng/l

1.32

118

Unspecified misadventure during surgical and medical care

131

1.22

0.27

1.0

36.00

44.69

ng/l

—

Other metabolic disorders

271

1.14

0.27

1.0

36.39

47.24

ng/l

0.84

182

Lymphoid leukaemia

128

0.78

0.26

1.2

1.0

39.80

44.93

ng/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

243

1.15

0.26

1.0

34.17

46.58

ng/l

1.67

168

Vascular disorders of the intestines

159

1.20

0.26

1.0

26.75

43.07

ng/l

—

100

Other arthritis (FG)

843

0.92

0.26

1.0

39.96

42.67

ng/l

0.28

579

ILD medications: azathioprine

319

1.13

0.26

1.0

40.27

44.11

ng/l

0.22

222

Hypertrophy of breast

338

1.12

0.26

1.0

40.99

42.00

ng/l

0.05

242

Iron deficiency anaemia secondary to blood loss (chronic)

405

0.89

0.26

1.0

49.41

43.53

ng/l

0.32

265

Other/unspecified rheumatoid arthritis

310

0.87

0.26

1.0

30.79

45.82

ng/l

1.79

197

Other otitis externa (chronic)

141

1.21

0.26

1.0

21.25

44.17

ng/l

—

Coagulation defects, purpura and other haemorrhagic conditions

436

0.89

0.26

1.0

42.70

43.78

ng/l

0.06

294

Endometriosis of ovary

333

0.88

0.25

1.0

45.35

44.46

ng/l

0.04

236

Other shoulder lesions

197

1.17

0.25

1.0

27.29

47.44

ng/l

3.89

134

Rash and other nonspecific skin eruption

213

0.84

0.25

1.1

1.0

48.54

46.64

ng/l

0.07

136

Ulcerative colitis, NAS

298

0.87

0.25

1.0

36.00

46.32

ng/l

1.04

207

Other necrotizing vasculopathies

179

1.17

0.25

1.0

41.43

45.81

ng/l

0.21

111

Unspecified jaundice

105

1.24

0.24

1.0

53.38

41.79

ng/l

—

Cholecystitis

361

0.89

0.24

1.0

40.06

44.22

ng/l

0.30

245

Other noninflammatory disorders of vulva and perineum

159

0.82

0.24

1.0

41.50

50.99

ng/l

—

113

Disorders of gallbladder, biliary tract and pancreas

300

1962

0.96

0.24

1.0

47.94

40.77

ng/l

0.47

192

1386

Undetermined asthma

329

0.88

0.24

1.0

49.70

47.87

ng/l

0.07

218

Undetermined asthma, excluding more controls

329

0.88

0.24

1.0

49.70

48.51

ng/l

0.04

216

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

359

1.11

0.24

1.0

40.33

43.57

ng/l

0.20

258

Other epidermal thickening

1.27

0.24

1.1

1.0

26.50

44.70

ng/l

—

Benign neoplasm of ovary

407

1.11

0.24

1.0

79.40

45.22

ng/l

0.36

282

Chronic sinusitis

120

1131

1.06

0.24

1.0

40.24

42.29

ng/l

0.22

788

Diabetic maculopathy

231

1.14

0.24

1.0

26.24

36.27

ng/l

1.37

163

Obesity

157

1591

0.95

0.24

1.0

31.94

42.16

ng/l

4.23

114

1126

All dysplastic lesions of the cervix uteri, vagina or vulva

406

0.90

0.23

1.0

29.68

42.15

ng/l

2.40

296

Maternal care for known or suspected abnormality of pelvic organs

188

0.87

0.23

1.0

35.31

42.39

ng/l

0.47

141

Macular pucker

474

0.91

0.23

1.0

34.90

43.94

ng/l

1.19

308

Pre-eclampsia

338

0.89

0.23

1.1

1.0

45.49

42.98

ng/l

0.13

243

Coeliac disease

256

1.13

0.23

1.0

26.43

44.13

ng/l

4.35

172

Benign neoplasm: Rectum, anus and anal canal

601

1.08

0.23

1.0

50.95

43.83

ng/l

0.38

394

Non-follicular lymphoma

264

0.87

0.23

1.0

48.76

44.39

ng/l

0.24

172

Bacterial pneumonia (organism specified)

113

1084

0.94

0.22

1.0

30.39

42.96

ng/l

6.84

725

Internal derangement of knee

111

1043

1.06

0.22

1.0

34.02

41.61

ng/l

1.72

735

Benign neoplasm: Vulva

1.25

0.22

1.0

76.80

55.15

ng/l

—

Certain disorders involving the immune mechanism

467

1.09

0.22

1.0

39.34

43.84

ng/l

0.45

324

Diabetic nephropathy

338

1.11

0.22

1.0

44.79

35.13

ng/l

1.01

219

Other and unspecified iron deficiency

865

0.94

0.22

1.0

41.34

43.94

ng/l

0.24

572

Other nonautoimmune haemolytic anaemias

0.00

0.21

0.0

1.0

—

41.60

—

Cytomegaloviral hepatitis

0.00

0.21

0.0

1.0

—

35.20

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.0

—

36.50

—

Endometriosis ASRM stages 1,2

286

1.12

0.21

1.0

45.60

44.35

ng/l

0.04

203

Toxic colitis

0.00

0.21

0.0

1.0

—

43.33

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.21

0.0

1.0

—

38.33

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.0

—

38.40

—

Pneumonia due to Haemophilus influenzae

0.00

0.21

0.0

1.0

—

44.80

—

Lupus nephritis

0.00

0.21

0.0

1.0

—

35.40

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.0

—

34.80

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

0.21

0.0

1.0

—

39.38

—

Systemic sclerosis, icd10

1.19

0.21

1.0

57.40

49.85

ng/l

—

Listeriosis

0.00

0.21

0.0

1.0

—

37.40

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.19

0.21

1.0

35.20

67.18

ng/l

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.0

—

36.20

—

Other congenital malformations of urinary system

0.00

0.21

0.0

1.0

—

38.00

—

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

1.0

—

35.20

—

Other specified transport accidents

0.00

0.21

0.0

1.0

—

47.60

—

Other superficial injuries of ankle and foot

0.00

0.21

0.0

1.0

—

43.55

—

Clubfoot

0.00

0.21

0.0

1.0

—

34.80

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

36.00

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.21

0.0

1.0

—

48.50

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.0

—

36.29

—

Allergic bronchopulmonary aspergillosis (ABPA)

0.00

0.21

0.0

1.0

—

38.12

—

Nezelof syndrome

0.00

0.21

0.0

1.0

—

29.19

—

Malignant neoplasm of gum

0.00

0.21

0.0

1.0

—

41.33

—

Congenital cataract

0.00

0.21

0.0

1.0

—

41.00

—

Congenital malformations of oesophagus

0.00

0.21

0.0

1.0

—

29.00

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

33.50

—

Other dermatomyositis

0.00

0.21

0.0

1.0

—

41.00

—

Severe visual impairment, binocular

0.00

0.21

0.0

1.0

—

44.17

—

Melanocytic naevi of ear and external auricular canal

0.00

0.21

0.0

1.0

—

30.86

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

44.17

—

Dacryoadenitis

0.00

0.21

0.0

1.0

—

44.00

—

Diastasis of muscle

0.00

0.21

0.0

1.0

—

31.33

—

Assault by other specified means

0.00

0.21

0.0

1.0

—

32.86

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.21

0.0

1.0

—

30.14

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.21

0.0

1.0

—

31.83

—

Enterobiasis

0.00

0.21

0.0

1.0

—

39.71

—

Striking against or struck by other objects

700

1.07

0.21

1.0

36.00

40.97

ng/l

0.85

484

Primary coxarthrosis, bilateral

874

0.94

0.21

1.0

37.12

44.11

ng/l

1.24

576

Plantar fascial fibromatosis

220

1.14

0.21

1.0

37.09

45.81

ng/l

0.94

146

Degeneration of macula and posterior pole

143

1193

0.95

0.21

1.0

41.45

43.68

ng/l

0.29

781

Left side

0.00

0.21

0.0

1.0

—

29.63

—

0.00

0.21

0.0

1.0

—

41.88

—

Other/unspecified mastoiditis and related conditions

0.00

0.21

0.0

1.0

—

38.00

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

41.88

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

31.29

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.0

—

42.50

—

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.0

—

33.50

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.0

—

36.33

—

Drug-induced systemic lupus erythematosus

0.00

0.21

0.0

1.0

—

39.43

—

Acute inflammation of orbit

0.00

0.21

0.0

1.0

—

38.17

—

Acute myringitis

0.00

0.21

0.0

1.0

—

40.29

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.21

0.0

1.0

—

41.13

—

Mesial bite

0.00

0.21

0.0

1.0

—

37.14

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.21

0.0

1.0

—

31.50

—

Other peripheral vertigo

230

0.87

0.21

1.1

1.0

39.87

45.37

ng/l

0.42

145

Codeine or tramadol medication

344

1825

1.03

0.21

1.0

41.14

42.59

ng/l

0.09

239

1265

HSIL lesion of the cervix uteri, vagina or vulva

230

0.87

0.21

1.1

1.0

32.50

45.19

ng/l

1.34

167

Excessive, frequent and irregular menstruation

431

1.07

0.20

1.0

39.31

44.36

ng/l

0.57

302

Benign neoplasm of other and ill-defined parts of digestive system

489

1.08

0.20

1.1

1.0

42.03

44.62

ng/l

0.16

334

Septicaemia

125

1112

1.05

0.20

1.0

37.81

43.75

ng/l

1.31

746

Rheumatoid lung disease

0.00

0.20

0.0

1.0

—

36.14

—

Carcinoma in situ of endometrium

0.00

0.20

0.0

1.0

—

28.78

—

Blindness or visual impairment, binocular

0.00

0.20

0.0

1.0

—

38.13

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.20

0.0

1.0

—

32.22

—

Benign neoplasm: Retina

0.00

0.20

0.0

1.0

—

42.50

—

Reiter disease

0.00

0.20

0.0

1.0

—

39.61

—

Exposure to other and unspecified forces of nature

0.00

0.20

0.0

1.0

—

38.91

—

Malignant neoplasm of penis, including Hilmo

0.00

0.20

0.0

1.0

—

29.70

—

Serous carcinoma of ovary

0.00

0.20

0.0

1.0

—

40.00

—

Carcinoma in situ of breast, lobular

0.00

0.20

0.0

1.0

—

34.89

—

Pedal cyclist injured in noncollision transport accidents

240

1.13

0.20

1.0

40.55

46.38

ng/l

0.33

156

Artrosis, including avohilmo

258

1364

1.04

0.20

1.0

39.12

42.73

ng/l

0.65

180

971

Major coronary heart disease event

300

1754

1.03

0.20

1.0

39.88

42.14

ng/l

0.37

192

1257

Other disorders of iris and ciliary body

1.20

0.19

1.0

32.83

42.22

ng/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.20

0.19

1.0

43.00

36.11

ng/l

—

Acne

1.20

0.19

1.2

1.0

22.67

26.77

ng/l

—

Nontoxic goitre/thyroid nodule

799

0.94

0.19

1.0

43.73

43.13

ng/l

0.03

541

Calcific tendinitis of shoulder

127

1.18

0.19

1.0

37.48

46.40

ng/l

—

Diabetic retinopathy, strict definition

305

1.10

0.19

1.0

35.37

35.99

ng/l

0.04

210

Other spirochaetal diseases

840

1.06

0.19

1.0

43.15

42.50

ng/l

0.06

576

Hypokalaemia

298

1.11

0.19

1.1

1.0

34.91

47.88

ng/l

0.87

197

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

333

0.90

0.19

1.0

40.70

44.71

ng/l

0.24

222

Calculus of kidney and ureter

839

0.94

0.19

1.0

39.14

42.16

ng/l

0.27

576

Stenosis and insufficiency of lacrimal passages

203

1.13

0.19

1.1

1.0

34.32

44.51

ng/l

1.18

130

Other anaemias

117

1167

0.95

0.19

1.0

42.14

43.45

ng/l

0.15

758

Congenital malformations, deformations and chromosomal abnormalities

132

1201

1.05

0.18

1.0

40.17

39.89

ng/l

0.03

849

Carcinoma in situ of breast, intraductal

217

0.87

0.18

1.0

51.07

50.00

ng/l

0.04

151

Other or unspecified ileus, impaction or obstruction

482

1.08

0.18

1.0

35.65

45.41

ng/l

1.35

323

All chronic kidney diseases

149

1270

0.96

0.18

1.0

39.96

42.39

ng/l

0.38

105

844

Unspecified acute lower respiratory infection

328

1.10

0.18

1.0

35.23

43.77

ng/l

0.75

226

Spirochaetal infections, other/unspecified

833

1.06

0.18

1.0

42.86

42.46

ng/l

0.04

572

Other disorders of patella

373

0.91

0.18

1.0

55.64

42.69

ng/l

0.69

267

Contact with machinery

300

0.90

0.18

1.0

44.64

39.74

ng/l

0.26

209

Oral corticosteroids

323

1864

1.03

0.17

1.0

46.21

40.85

ng/l

0.38

221

1308

Vestibular neuronitis

233

1.12

0.17

1.0

41.67

46.42

ng/l

0.18

149

Thyrotoxicosis

599

0.93

0.17

1.0

36.22

43.78

ng/l

0.97

407

Pregnancy with abortive outcome

147

798

0.96

0.16

1.0

48.64

44.19

ng/l

0.48

100

566

Other and unspecified anaemias

117

1164

0.96

0.16

1.0

42.14

43.45

ng/l

0.15

756

Ptosis of eyelid

292

1.10

0.16

1.1

1.0

21.33

44.43

ng/l

9.70

193

Presence of other functional implants

196

1404

0.97

0.16

1.0

40.87

43.83

ng/l

0.41

135

958

Vitreous haemorrhage

256

0.90

0.16

1.0

40.44

43.14

ng/l

0.10

170

Diffuse large B-cell lymphoma, including Hilmo

130

0.85

0.16

1.0

42.50

49.38

ng/l

—

Diffuse large B-cell lymphoma, helper endpoint

130

0.85

0.16

1.0

42.50

49.38

ng/l

—

Diffuse large B-cell lymphoma

130

0.85

0.16

1.0

42.50

49.38

ng/l

—

Pediculosis, acariasis and other infestations

283

1.10

0.15

1.1

1.0

39.29

43.20

ng/l

0.26

191

Retinal breaks without detachment

467

1.07

0.15

1.0

51.74

41.69

ng/l

0.84

317

Visual field defects

193

0.88

0.15

1.1

1.0

55.50

44.37

ng/l

0.57

124

Chronic pancreatitis

349

0.92

0.15

1.0

28.39

43.88

ng/l

2.67

249

Chronic laryngitis and laryngotracheitis

380

1.08

0.15

1.0

44.71

43.00

ng/l

0.12

263

Ulcerative colitis

555

1.06

0.15

1.0

31.38

43.59

ng/l

3.10

385

Diabetes mellitus in pregnancy

177

0.90

0.15

1.0

32.64

41.40

ng/l

0.87

137

Chronic nephritic syndrome

1.11

0.15

1.2

1.0

53.62

39.73

ng/l

—

Benign leiomyoma with endometriosis

371

1.08

0.15

1.0

45.08

46.80

ng/l

0.07

253

Other disorders of kidney and ureter

342

1.08

0.15

1.0

35.37

44.11

ng/l

0.90

227

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

172

1753

0.97

0.15

1.0

38.15

42.95

ng/l

1.03

118

1204

Other specified/unspecified arthritis

728

0.95

0.15

1.0

40.51

42.04

ng/l

0.13

495

Other specified/unspecified soft tissue disorders

1.18

0.14

1.0

24.50

45.47

ng/l

—

Zoster [herpes zoster]

469

1.07

0.14

1.1

1.0

32.74

45.28

ng/l

2.13

314

Thiazolidinediones

343

1.08

0.14

1.1

1.0

29.45

45.87

ng/l

2.81

228

Pre-eclampsia or poor fetal growth

438

0.93

0.14

1.0

42.70

41.87

ng/l

0.05

314

Zoster [herpes zoster]

143

1455

0.97

0.13

1.0

37.43

44.02

ng/l

0.74

995

Explicit bacterial Sepsis

170

0.88

0.13

1.0

34.40

45.76

ng/l

—

Injury of other and unspecified intrathoracic organs

149

0.87

0.13

1.0

32.25

42.89

ng/l

—

Perforation of tympanic membrane

218

1.10

0.13

1.0

39.68

46.02

ng/l

0.41

140

Disorders of vitreous body and globe

173

1612

1.03

0.13

1.0

45.84

43.00

ng/l

0.34

122

1118

Rosacea

247

1.09

0.13

1.0

45.53

45.76

ng/l

0.01

166

Deep bite

149

0.88

0.13

1.0

35.90

43.50

ng/l

—

Thyrotoxicosis, other and/or unspecified

459

0.94

0.13

1.0

33.74

45.36

ng/l

1.77

324

Haemangioma and lymphangioma, any site

201

0.90

0.13

1.0

55.46

44.97

ng/l

0.56

126

Atrial fibrillation and flutter

100

622

1.04

0.13

1.0

43.52

45.10

ng/l

0.14

466

Disorders of calcium metabolism

151

1.13

0.13

1.0

31.33

47.17

ng/l

—

Congenital malformations, deformations and chromosomal abnormalities

151

1347

1.03

0.13

1.0

39.20

41.69

ng/l

0.30

106

944

Benign neoplasm: salivary glands, exclude unknown (D119)

232

0.90

0.13

1.0

49.69

45.05

ng/l

0.14

150

Blepharochalasis

892

1.04

0.13

1.0

41.15

46.51

ng/l

0.47

593

Other bacterial intestinal infections

432

1.07

0.13

1.0

36.20

44.21

ng/l

1.19

286

Nontoxic multinodular goitre

520

0.94

0.13

1.0

44.97

46.07

ng/l

0.04

354

Chondropathies

325

1.08

0.13

1.0

35.00

45.38

ng/l

1.28

228

Other disorders of eyelid

144

1327

1.03

0.13

1.0

36.19

44.72

ng/l

1.46

901

Lichen sclerosus et atrophicus

238

1.09

0.13

1.0

42.15

45.10

ng/l

0.08

161

LSIL lesion of the cervix uteri, vagina or vulva

190

1.11

0.12

1.0

32.07

45.07

ng/l

1.31

142

Other viral diseases, not elsewhere classified

344

1.07

0.12

1.0

36.77

43.05

ng/l

0.49

236

Glomerular disorders in diseases classified elsewhere

283

0.92

0.12

1.0

48.90

42.91

ng/l

0.35

188

Salpingitis and oophoritis

427

0.94

0.12

1.1

1.0

89.74

43.91

ng/l

0.38

301

Non-allergic asthma

190

1.10

0.12

1.0

54.36

47.95

ng/l

0.24

118

Lichen planus

355

1.07

0.12

1.1

1.0

40.42

45.46

ng/l

0.32

237

Dislocation, sprain and strain of joints and ligaments of knee

152

1443

0.97

0.12

1.0

34.12

42.43

ng/l

1.82

110

1032

Viral infections characterized by skin and mucous membrane lesions

235

2056

0.98

0.12

1.0

37.06

42.04

ng/l

0.87

161

1444

Endometriosis of pelvic peritoneum

283

1.08

0.12

1.0

45.60

46.25

ng/l

0.02

204

Unspecified kidney failure

239

1.09

0.12

1.0

30.08

44.35

ng/l

1.68

149

Ethmoidectomy

313

0.93

0.12

1.0

42.77

45.53

ng/l

0.15

216

Coxarthrosis, primary

197

1710

0.97

0.12

1.0

39.25

43.40

ng/l

0.78

124

1175

Scoliosis

133

1.13

0.12

1.0

39.16

48.79

ng/l

—

Cholesteatoma of middle ear

116

0.86

0.12

1.1

1.0

25.40

45.30

ng/l

—

Reactive arthropathies

199

0.90

0.11

1.0

45.15

46.95

ng/l

0.06

139

Retained placenta and membranes, without haemorrhage

230

0.91

0.11

1.1

1.0

145.66

44.99

ng/l

0.55

163

Other complications of surgical and medical care, not elsewhere classified

230

1.09

0.11

1.0

32.21

44.47

ng/l

1.29

144

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

172

1.11

0.11

1.1

1.0

36.31

45.25

ng/l

0.61

107

Other nutritional deficiencies

170

1642

0.97

0.11

1.0

30.83

42.14

ng/l

5.61

122

1158

Disorders of mineral metabolism

211

1.09

0.11

1.0

28.23

48.43

ng/l

3.00

138

Osteonecrosis

153

1.11

0.11

1.0

41.82

47.31

ng/l

0.24

Infections with a predominantly sexual mode of transmission

542

1.05

0.11

1.0

36.46

41.67

ng/l

0.65

377

Obesity due to excess calories

120

1163

1.03

0.11

1.0

30.58

41.08

ng/l

5.20

816

Postprocedural endocrine and metabolic disorders, not elsewhere classified

250

1.08

0.11

1.0

39.55

46.70

ng/l

0.42

167

Suppurative and unspecified otitis media

466

0.95

0.10

1.0

38.55

41.74

ng/l

0.31

320

Lyme disease

829

1.04

0.10

1.0

42.63

42.58

ng/l

0.00

569

Autoimmune diseases related-to ILD

235

2051

0.98

0.10

1.0

36.35

42.33

ng/l

1.54

157

1444

Infective dermatitis

280

0.93

0.10

1.0

40.71

45.20

ng/l

0.20

188

Rheumatoid arthritis

845

0.97

0.10

1.0

40.80

43.06

ng/l

0.23

574

Diseases of salivary glands

800

0.96

0.10

1.0

37.14

43.03

ng/l

1.13

552

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

319

1.07

0.10

1.0

36.65

44.62

ng/l

0.92

223

Dermatitis

178

1732

1.02

0.10

1.0

35.06

41.50

ng/l

2.15

119

1203

Other and unspecified disorders of vitreous body

143

1373

1.03

0.10

1.0

46.37

43.26

ng/l

0.35

104

950

Benign lipomatous neoplasm of other sites/unspecified

218

0.92

0.10

1.0

36.19

44.78

ng/l

0.81

137

Inguinal hernia, bilateral

290

1.07

0.10

1.0

35.36

42.48

ng/l

0.49

189

Disorders of vitreous body

168

1584

1.02

0.10

1.0

45.96

42.96

ng/l

0.36

121

1100

Artificial joint operation, meniscal resection

298

1968

0.98

0.10

1.0

44.50

41.56

ng/l

0.55

201

1386

Systemic sclerosis (FG)

1.11

0.10

1.0

57.40

60.39

ng/l

—

Benign neoplasm: Skin of eyelid, including canthus

408

1.05

0.09

1.1

1.0

43.80

42.94

ng/l

0.04

274

Percutaneous Coronary Intervention

277

1667

1.02

0.09

1.0

40.52

42.21

ng/l

0.23

169

1196

Systemic sclerosis

1.09

0.09

1.0

57.40

51.26

ng/l

—

5-aminosalicylic acid

467

1.05

0.09

1.0

36.92

43.84

ng/l

0.65

329

102

981

1.03

0.09

1.0

41.12

41.81

ng/l

0.05

674

Other specific arthropathies, wide

1.06

0.09

1.0

34.40

49.54

ng/l

—

Other diseases of blood and blood-forming organs

176

0.91

0.09

1.0

43.55

44.30

ng/l

0.02

107

Aggressive periodontitis

1.04

0.09

1.2

1.0

36.60

41.39

ng/l

—

Neoplasms

207

1074

1.02

0.09

1.0

41.25

40.09

ng/l

0.14

147

743

Adverse effects, not elsewhere classified

389

1.05

0.09

1.0

47.64

44.80

ng/l

0.15

266

Scabies

213

1.08

0.09

1.1

1.0

41.29

40.66

ng/l

0.03

139

Benign neoplasm of bone and articular cartilage

165

0.91

0.08

1.0

17.61

41.74

ng/l

—

100

Coronary atherosclerosis

240

1491

1.02

0.08

1.0

39.84

43.27

ng/l

0.50

157

1057

Other embolism and thrombosis

331

1.06

0.08

1.1

1.0

41.13

42.63

ng/l

0.10

225

Other specified/unspecified hearing loss

204

1.08

0.08

1.1

1.0

37.24

43.57

ng/l

0.51

131

Long labour

264

0.94

0.08

1.0

61.33

39.54

ng/l

1.38

201

Embedded and impacted teeth

187

0.93

0.08

1.0

27.77

41.48

ng/l

1.92

121

Other and unspecified disease of Bartholin gland

1.05

0.08

1.0

26.50

53.91

ng/l

—

Foreign body on external eye

349

0.95

0.08

1.0

36.73

39.75

ng/l

0.23

249

Disorders of optic nerve and visual pathways

175

1.09

0.08

1.0

40.75

44.41

ng/l

0.17

109

Acute pancreatitis (for exclusion)

542

0.96

0.08

1.0

45.51

42.92

ng/l

0.21

369

Glomerulonephritis

226

0.93

0.08

1.1

1.0

44.84

43.74

ng/l

0.03

147

Atrophic disorders of skin

328

0.94

0.08

1.0

44.24

44.97

ng/l

0.02

221

Urolithiasis

916

0.97

0.08

1.0

38.76

41.97

ng/l

0.31

623

Other specified and unspecified disorders of eye and adnexa

1.04

0.08

1.0

54.71

43.00

ng/l

—

Inguinal or femoral hernia, bilateral

293

1.06

0.08

1.0

35.36

42.48

ng/l

0.49

190

Postmenopausal atrophic vaginitis

422

0.97

0.08

1.0

39.37

44.67

ng/l

0.66

298

Sulfasalazine

786

1.03

0.07

1.0

41.31

43.22

ng/l

0.14

548

Vasomotor rhinitis (mode)

166

1.08

0.07

1.0

43.08

45.12

ng/l

0.10

106

Benign neoplasm: Pancreas

0.83

0.07

1.0

25.33

48.83

ng/l

—

Use of rasagiline

0.82

0.07

1.2

1.0

26.00

43.87

ng/l

—

Malignant neoplasm of endocrine gland

174

0.92

0.07

1.0

35.14

51.88

ng/l

0.66

112

Dyspnoea

275

2002

1.01

0.07

1.0

37.09

42.36

ng/l

1.29

186

1406

Other spirochaetal diseases

836

1.03

0.07

1.0

42.63

42.59

ng/l

0.00

574

Spontaneous abortion

685

0.97

0.07

1.0

37.37

43.84

ng/l

0.80

503

Gestational [pregnancy-induced] hypertension

342

1.05

0.07

1.1

1.0

36.81

42.40

ng/l

0.46

248

Malignant neoplasm of thyroid gland, including Hilmo

184

0.92

0.07

1.0

35.14

49.98

ng/l

0.58

119

Contraceptive management

691

0.97

0.07

1.0

42.00

41.33

ng/l

0.04

525

Pacemaker

906

1.03

0.07

1.0

42.94

44.07

ng/l

0.10

576

Obesity, other/unspecified

752

0.97

0.07

1.0

32.39

40.86

ng/l

1.58

535

Localized swelling, mass and lump of skin and subcutaneous tissue

853

0.97

0.07

1.0

37.19

42.44

ng/l

0.68

586

Acute pancreatitis

539

0.96

0.07

1.0

45.51

42.62

ng/l

0.24

378

Benign neoplasm of mouth and pharynx

265

1.06

0.07

1.1

1.0

25.10

45.16

ng/l

5.27

173

Other/unspecified synovitis and tenosynovitis

265

1.06

0.07

1.0

42.64

46.44

ng/l

0.17

184

Other benign neoplasms of skin

101

1034

0.98

0.06

1.0

42.78

42.98

ng/l

0.02

704

Symptoms and signs involving the skin and subcutaneous tissue

195

1938

0.98

0.06

1.0

47.59

41.49

ng/l

0.27

141

1336

Other abnormal uterine and vaginal bleeding

393

0.97

0.06

1.0

38.09

45.34

ng/l

0.77

273

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

138

1.09

0.06

1.1

1.0

36.11

47.78

ng/l

—

Medical abortion

144

796

0.98

0.06

1.0

48.97

44.19

ng/l

0.47

101

566

347

1772

1.01

0.06

1.0

37.76

42.41

ng/l

1.53

237

1236

Triptan medication for migraine, single purchase ok

193

1327

0.98

0.06

1.0

37.51

42.43

ng/l

0.91

135

963

Migraine, single triptan purchase ok & required. ICD-code if available is included

193

1327

0.98

0.06

1.0

37.51

42.43

ng/l

0.91

135

963

Acute appendicitis, no complications

139

1408

0.98

0.06

1.0

36.66

39.46

ng/l

0.57

104

1005

Persons encountering health services in circumstances related to reproduction

148

1014

0.98

0.06

1.0

40.92

41.93

ng/l

0.08

108

752

Disorders of muscles

223

0.94

0.06

1.0

35.77

45.86

ng/l

0.81

152

Ulcerative colitis (strict definition, all Crohn cases excluded)

286

1.05

0.06

1.0

36.45

45.86

ng/l

1.03

194

Smoking dependency

227

1.06

0.06

1.1

1.0

30.40

44.90

ng/l

2.18

153

Any death

215

1560

0.99

0.06

1.0

44.54

43.39

ng/l

0.14

151

1066

Pre-eclampsia or eclampsia

375

0.96

0.05

1.1

1.0

46.10

43.16

ng/l

0.16

269

Emergency coronary revascularization (for ACS)

299

1797

1.01

0.05

1.0

39.81

42.14

ng/l

0.36

184

1284

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

685

0.97

0.05

1.0

33.84

40.26

ng/l

0.66

494

Inflammatory bowel disease treatment related agents

337

1865

1.01

0.05

1.0

44.16

40.83

ng/l

0.23

237

1309

Other maternal disorders predominantly related to pregnancy

125

798

0.98

0.05

1.0

38.65

44.48

ng/l

0.85

588

Viral infections characterized by skin and mucous membrane lesions

103

1049

0.98

0.05

1.0

32.70

42.32

ng/l

2.62

720

Hernia of abdominal wall, postoperative

475

0.97

0.05

1.0

37.22

43.05

ng/l

0.49

376

Tuberculosis, IBD comorbidity

159

1.07

0.05

1.1

1.0

25.30

43.17

ng/l

—

Umbilical hernia

717

0.98

0.05

1.0

46.64

41.79

ng/l

0.23

509

Mental and behavioural disorders due to tobacco

228

1.05

0.05

1.1

1.0

30.40

45.07

ng/l

2.22

153

Iron deficiency anaemia

109

1093

0.98

0.05

1.0

45.17

43.61

ng/l

0.14

729

Foreign body or object entering through skin

120

0.92

0.05

1.1

1.0

29.91

39.13

ng/l

0.75

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

163

1649

0.99

0.04

1.0

38.18

42.98

ng/l

0.97

111

1130

Benign neoplasm: Parotid gland

201

0.94

0.04

1.1

1.0

49.69

45.04

ng/l

0.14

126

Coronary revascularization (ANGIO or CABG)

275

1667

1.01

0.04

1.0

40.36

42.21

ng/l

0.25

172

1196

Postmenopausal bleeding

423

1.02

0.04

1.0

41.10

44.56

ng/l

0.32

299

Obesity related asthma

953

1.02

0.04

1.0

39.14

41.98

ng/l

0.30

657

Necrosis of pulp, including avohilmo

151

1486

1.01

0.04

1.0

42.02

40.84

ng/l

0.11

116

1052

Other diseases of pancreas

231

0.95

0.04

1.0

34.00

44.39

ng/l

0.82

158

Normotensive glaucoma

229

1.05

0.04

1.0

46.89

44.53

ng/l

0.12

148

Glomerular diseases

443

0.97

0.04

1.0

47.24

44.44

ng/l

0.17

299

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

241

0.95

0.04

1.0

39.23

45.28

ng/l

0.33

153

Other diseases of stomach and duodenum

160

1.06

0.04

1.0

51.67

40.78

ng/l

0.36

Suggestive for eosinophilic asthma

251

0.96

0.04

1.0

46.53

43.95

ng/l

0.11

167

Haemangioma, any site

190

0.95

0.04

1.0

55.46

46.38

ng/l

0.46

117

Artificial joint re-operation

190

0.95

0.04

1.1

1.0

43.92

47.49

ng/l

0.23

117

Acute upper respiratory infections

304

1887

0.99

0.04

1.0

37.04

43.02

ng/l

1.85

218

1309

Benign neoplasm: Descending colon

200

1.05

0.03

1.0

72.67

44.75

ng/l

0.51

128

Presbycusis

306

1.04

0.03

1.1

1.0

33.86

45.67

ng/l

1.34

185

Ulcerative colitis (strict definition, require KELA)

329

1.03

0.03

1.0

36.65

43.99

ng/l

0.83

231

Paroxysmal tachycardia

496

0.98

0.03

1.1

1.0

37.55

46.14

ng/l

1.59

364

Acute peritonitis

141

1.06

0.03

1.0

29.60

43.87

ng/l

—

Fracture of foot, except ankle

518

1.02

0.03

1.1

1.0

39.91

42.27

ng/l

0.16

367

Macular hole

161

1.06

0.03

1.0

49.45

44.11

ng/l

0.18

Tuberculosis, wide

161

1.06

0.03

1.1

1.0

25.30

45.79

ng/l

—

Duodenal ulcer

270

1.04

0.03

1.0

42.41

44.69

ng/l

0.13

166

Menorrhagia

431

1.02

0.03

1.1

1.0

37.68

44.36

ng/l

1.12

302

Gonarthrosis,primary

312

1909

1.01

0.03

1.0

41.30

41.99

ng/l

0.11

212

1350

Other local infections of skin and subcutaneous tissue

231

1.04

0.02

1.0

35.72

45.61

ng/l

0.80

150

Superficial injury of shoulder and upper arm

241

1.04

0.02

1.0

41.94

42.90

ng/l

0.03

160

Injury of unspecified body region

148

0.95

0.02

1.0

46.93

44.11

ng/l

—

Intestinal stricture

869

1.01

0.02

1.0

34.96

43.59

ng/l

1.91

588

Otosclerosis

188

0.96

0.02

1.0

61.91

45.43

ng/l

0.58

118

Sequelae of injuries of lower limb

198

0.96

0.02

1.1

1.0

37.08

45.77

ng/l

0.55

127

Sequelae of external causes of morbidity and mortality

660

0.98

0.02

1.0

32.97

44.30

ng/l

2.57

443

Bacterial pneumoniae

112

977

1.01

0.02

1.0

30.24

43.64

ng/l

7.32

663

False labour

194

1.03

0.02

1.0

29.41

42.14

ng/l

1.48

153

Bronchiectasis

228

0.96

0.02

1.0

37.62

46.88

ng/l

0.82

140

Dental pulpitis, including avohilmo

250

1613

1.01

0.02

1.0

40.11

41.44

ng/l

0.15

181

1160

Abrasion of teeth

920

1.01

0.02

1.0

53.84

41.97

ng/l

0.28

644

Cutaneous abscess, furuncle and carbuncle

589

0.98

0.02

1.0

31.62

42.45

ng/l

1.75

412

Other disorders of the genitourinary system

322

1.03

0.01

1.0

54.93

47.71

ng/l

0.38

212

Seborrhoeic keratosis

651

1.01

0.01

1.0

39.65

43.76

ng/l

0.37

443

Methotrexate

372

1.02

0.01

1.0

45.71

45.61

ng/l

0.00

263

Bacterial intestinal infections, IBD co-morbidities

442

1.02

0.01

1.0

39.72

44.30

ng/l

0.43

295

Asthma, including avohilmo

343

1933

1.00

0.01

1.0

45.12

40.89

ng/l

0.30

232

1357

Angina pectoris

204

1366

0.99

0.01

1.0

36.79

43.85

ng/l

1.62

140

957

Acute sinusitis

122

1121

1.01

0.01

1.0

35.10

41.23

ng/l

1.18

782

Candidiasis

317

0.98

0.01

1.0

42.84

44.90

ng/l

0.12

206

Arthropod-borne viral fevers and viral haemorrhagic fevers

437

0.98

0.01

1.0

31.22

44.14

ng/l

2.53

297

Viral haemorrhagic fevers, not elsewhere classified/unspecified

386

0.98

0.00

1.1

1.0

32.73

45.41

ng/l

2.31

261

Inflammatory disease of uterus

206

0.97

0.00

1.0

43.91

46.77

ng/l

0.14

142

Other disorders of conjunctiva

374

1.02

0.00

1.0

44.74

43.55

ng/l

0.07

245

Other blood glucose lowering drugs, excl. Insulins

474

1.01

0.00

1.0

40.89

45.15

ng/l

0.27

312

Nutritional anaemias

135

1295

1.00

0.00

1.0

42.25

43.07

ng/l

0.08

854

Acute suppurative otitis media

287

1.01

0.00

1.1

1.0

32.71

42.82

ng/l

1.49

185

Other obstetric conditions, not elsewhere classified

105

1.03

0.00

1.0

39.09

36.31

ng/l

0.09

Bacterial pneumonia, not elsewhere classified

105

922

1.00

0.00

1.0

30.05

43.28

ng/l

6.71

625

Complications of internal orthopaedic prosthetic devices, implants and grafts

666

1.01

0.00

1.0

37.34

45.03

ng/l

1.35

436

Other and unspecified drugs and medicaments

188

1.01

0.00

1.1

1.0

27.36

45.94

ng/l

3.14

113

Benign neoplasm: Skin of other and unspecified parts of face

252

0.99

0.00

1.0

36.72

45.38

ng/l

0.63

165

Dermatographic urticaria

115

0.96

0.00

1.0

45.50

46.10

ng/l

—

Malignant neoplasm of thyroid gland

165

0.97

0.00

1.0

35.14

51.07

ng/l

0.63

105

Glaucoma, exfoliation

252

0.99

0.00

1.1

1.0

40.43

43.74

ng/l

0.23

158

Leiomyoma of uterus

160

906

1.00

0.00

1.0

40.70

45.22

ng/l

0.50

121

639

conjunctival haemorrhage

195

0.97

0.00

1.0

44.40

45.32

ng/l

0.03

122

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.00

0.00

1.0

39.70

37.80

ng/l

—

FESS (DNB20)

295

0.98

0.00

1.0

42.77

45.18

ng/l

0.13

201

Hallux rigidus

415

0.99

0.00

1.0

49.56

45.36

ng/l

0.25

283

Melanocytic naevi of other and unspecified parts of face

114

0.96

0.00

1.0

51.20

47.02

ng/l

—

Hyperkalaemia

124

0.97

0.00

1.0

27.51

48.05

ng/l

—

Cysts of oral region, not elsewhere classified

134

0.97

0.00

1.0

48.13

42.59

ng/l

—

Hallux valgus (acquired)

104

748

1.00

0.00

1.0

47.56

43.81

ng/l

0.30

513

Oral lichen planus, including avohilmo , including avohilmo

164

0.98

0.00

1.0

44.55

44.32

ng/l

0.01

113

Pedal cyclist injured in other and unspecified transport accidents

244

0.98

0.00

1.0

29.80

43.40

ng/l

1.86

162

Mixed hyperlipidaemia

1.02

0.00

1.0

29.26

46.36

ng/l

—

Benign neoplasm: Caecum

303

0.99

0.00

1.1

1.0

64.03

45.80

ng/l

0.36

195

Nontoxic single thyroid nodule

172

0.99

0.00

1.0

47.14

47.66

ng/l

0.02

116

Unspecified lump in breast

342

0.99

0.00

1.0

36.26

44.88

ng/l

0.92

238

Spontaneous rupture of synovium and tendon

222

0.99

0.00

1.0

55.23

45.78

ng/l

0.39

154

Sequelae with surgical and medical care as external cause

542

1.00

0.00

1.0

31.19

44.51

ng/l

3.38

364

LSIL lesion of the cervix uteri

129

1.01

0.00

1.0

34.99

46.18

ng/l

—

Sicca syndrome [Sjögren]

201

0.99

0.00

1.0

38.17

44.35

ng/l

0.31

135

Other and unspecified local infections of skin and subcutaneous tissue

219

1.00

0.00

1.0

35.72

45.94

ng/l

0.83

143

Diseases of peritoneum

251

1.00

0.00

1.0

35.08

45.93

ng/l

0.80

162

Other and unspecified rosacea

196

1.02

0.00

1.0

52.58

47.15

ng/l

0.19

128

Entropion and trichiasis of eyelid

207

1.01

0.00

1.0

31.65

43.33

ng/l

0.67

125

Intestinal adhesions without obstruction

214

0.98

0.00

1.0

30.75

45.47

ng/l

1.27

144

Follicular cysts of skin and subcutaneous tissue

439

1.00

0.00

1.0

39.75

42.42

ng/l

0.22

308

Unspecified abortion

1.02

0.00

1.0

45.40

49.09

ng/l

—

Asthma and opportunity respiratory infection

113

0.97

0.00

1.0

43.83

46.67

ng/l

—

Familial hypercholesterolemia, with ischemic heart disease

263

0.99

0.00

1.0

37.25

43.03

ng/l

0.44

167

Contact with other sharp object(s)

1.03

0.00

1.0

30.70

40.81

ng/l

—

Fall on and from ladder

203

0.99

0.00

1.1

1.0

27.08

41.60

ng/l

1.07

132

Other secondary coxarthrosis

1.01

0.00

1.0

23.71

45.69

ng/l

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.0

—

47.00

—

Other coagulation defects

130

1.00

-0.00

1.0

50.81

45.08

ng/l

—

Other disorders of adrenal gland

0.89

-0.00

1.0

41.29

43.69

ng/l

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.0

—

31.20

—

Cyst of Bartholin Gland

0.95

-0.00

1.3

1.0

50.48

52.91

ng/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

200

1.00

-0.00

1.1

1.0

28.33

46.19

ng/l

3.21

125

Ependymoma

0.00

-0.00

0.0

1.0

—

47.43

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

52.33

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS